Common use of Other Defined Terms Clause in Contracts

Other Defined Terms. Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Number Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii7.4 (ii) Agreement Preamble Ancillary Agreements Approved Sale Section 11.10 Authorization 11.1 Arbitration Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b13.6 (i) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Baidu Capital Schedule I Beijing Libite Preamble Bluestone Schedule I Bright Sky Schedule I ChinaEquity Schedule I Company Preamble Company Benefit Plan Opportunity Section 4.13(a12.15 (iii) Company Common Stock Corporate Opportunity Section 4.5(a12.15 (iii) Company Cure Direct US Investor Section 12.7 (iii) Disclosing Party Section 12.9 (iii) Dispute Section 13.6 (i) Dissenting Member Section 11.4 Energy Schedule I Exclusive Option Period Section 10.1(e) Company Expenses Overrun 7.6 Exempted Securities Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant 7.3 Exempt Registrations Section 3.4 Corporate Records First Participation Notice Section 4.7(a7.4 (i) D&O Indemnified Parties Founder Preamble Four Vote Section 6.8(a9.1(i) Effective Time German Company Preamble Golden Brick Schedule I Xxxxxxxxxx Schedule I Haixia Schedule I Haitong Schedule I Hammer Capital Schedule I HK Company Preamble HKIAC Section 2.4(b13.6 (ii) ERISA HKIAC Rules Section 4.13(a13.6 (ii) Exchange Agent Xxxxxxxxx Schedule I Honor Best Schedule I Hubei Investment Preamble IDG Schedule I Jiangsu Weiran Preamble Image Frame Schedule I Indirect US Investor Section 3.2(a12.7 (iii) Expenses Cap Investor/ Investors Preamble Investor Directors Section 8.7(b9.1(i) Export Approvals Investment Affiliates Section 4.26(a) Extended End Date 12.15 Joy Capital Schedule I Lenovo Schedule I Long Winner Schedule I Magic Stone Schedule I mobike Global Schedule I Mount Putuo Schedule I Morespark Schedule I Nanjing Weilong Preamble New Financing Section 10.1(h) Financial Statements 7.6 New Financing Notice Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM 7.6 New Margin Capital Schedule I New Securities Section 5.12(a7.3 Nextev User Preamble Nextev Power Preamble NIO Technology Preamble Ordinary Director Section 9.1(i) HCM Shareholders’ Meeting Orient Hontai Schedule I Offer Price Section 8.2(b11.1 Originalwish Schedule I Oversubscription Participants Section 7.4 (ii) HoldCo Padmasree Schedule I Party/ Parties Preamble Incentive Equity Plan Palace Schedule I PFIC Annual Information Statement Section 6.10(a12.7(iii) Individual Financial Statements PFIC Shareholder Section 4.7(a)(ii12.7 (iii) Intended Tax Treatment Recitals Interim Period Preemptive Notice Section 6.1 JOBS Act 7.4 (i) Preemptive Right Section 5.6(a) K&S 7.1 Preemptive Rights Holder Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up 7.1 Prior Shareholders Agreement Recitals Merger Recitals Merger Right Pro Rata Share Section 3.1(a) Modification in Recommendation 7.2 Proposed Cooperation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.712.16

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Number Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii7.4(b) Agreement Preamble Ancillary Agreements Amendment Recitals Anti-Bribery Laws Section 11.10 Authorization 11.7 Arbitration Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b12.5(a) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Beijing WFOE Preamble Beijing Mrfresh Preamble Business Recitals Company Preamble Company Benefit Plan Affiliate Section 4.13(a11.7 Compliance Laws Section 11.9 Confidential Information Section 11.19(a) Direct US Investor Section 11.17(c) Dispute Section 12.5(a) Earn-out Shares Section 11.30 Exempt Registrations Section 3.4 First Participation Notice Section 7.4(a) Government Official Section 11.7 GS Entities Section 11.29 HK Company/HK Companies Preamble HKIAC Section 12.5(b) HKIAC Rules Section 12.5(b) Indirect US Investor Section 11.17(c) Investor Directors Section 9.1(a) Investor(s) Preamble Jinan Missfresh Extreme Preamble Jinan WFOE Preamble Major Subsidiary Section 9.1(c) Missfresh HK Company Common Stock Preamble Money Laundering Laws Section 4.5(a11.10 Mrfresh Cayman Preamble Mrfresh HK Company Preamble Mrfresh WFOE Preamble New Securities Section 7.3 Observer Section 9.4 ODI Approvals Section 11.3 OFAC Section 11.11 Ordinary Directors Section 9.1(a) Company Cure Original Purchase Agreement Recitals Oversubscription Participants Section 7.4(b) Party/Parties Preamble PFIC Shareholder Section 11.17(c) PRC Company/PRC Companies Preamble Preemptive Right Section 7.1 Principal/Principals Preamble Principal Holding Company/Principal Holding Companies Preamble Prior Agreements Recitals Pro Rata Share Section 7.2 Purchase Agreement Recitals Qualified Financing Section 11.30 Qualified Series F Investor Section 11.30 Sanctions Section 11.11 Second Participation Notice Section 7.4(b) Second Participation Period Section 10.1(e7.4(b) Company Expenses Overrun Security Holder Section 8.7(b11.3 Series A Investor(s) Company Indemnified Parties Preamble Series B Investor(s) Preamble Series C Investor(s) Preamble Series D1 Investor(s) Preamble Series E Investor(s) Preamble Series E1 Investor(s) Preamble Series F Investor(s) Preamble Subsidiary Board Section 6.8(a9.1(c) Company Real Property Third Amended and Restated SHA Recitals Violation Section 4.20(a5.1(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy StatementWFOE/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7WFOEs Preamble

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Consideration Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii12.11(iv) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Arbitration Notice Section 7.7 Cash Contribution 13.5(i) Australian Subsidiary Recitals Cayman Companies Act Recitals Xxxxxxxx Chance CFC Section 11.18(b12.5 Company Preamble Confidential Information Section 12.4(i) Clifford Chance Privileged Communications Dispute Section 11.18(b13.5(i) Clifford Chance Waiving Parties Exempt Registrations Section 11.18(b3.4 Extended Participation Period Section 7.4 Founder Section 10.1(i)(d) Clifford Chance WP Group Founder Director Section 11.18(b10.1(i)(d) Closing Fully Exercising Investor Section 2.4(a7.4 HKIAC Section 13.5(ii) Closing HKIAC Rules Section 13.5(ii) Holdco Subsidiary Preamble Indirect United States Shareholder Section 12.5 Initial Consideration Section 12.11(iv) Investor(s) Preamble Investor’s Partners Section 12.5 Liquidation Event Section 12.11(i) New Financing Section 10.1(iv) New Securities Section 7.3 Non-Competition Period Section 12.15 Ordinary Shareholders Preamble Participation Notice Section 7.4 Participation Period Section 7.4 Party(ies) Preamble Preemptive Right Section 7.1 Prohibited Payment Section 12.10 Pro Rata Share Section 7.2 Public Official Section 12.10 QIPO Date Section 2.4(a12.12(i) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Repurchase Date Section 10.1(h12.12(i) Financial Statements Repurchase Notice Section 4.7(a)(ii12.12(v) FTA Repurchase Price Section 4.15(y12.12(iii) Government Contract Repurchase Request Section 4.29 HCM 12.12(i) Requesting Series A Holders Section 12.12(1) Requesting Series B Holders Section 12.12(i) Requesting Series C Holders Section 12.12(i) Rights Holder Section 7.1 Series A Repurchase Notice Section 12.12(i) Series A Shareholders Preamble HCM Cure Period Series B Repurchase Notice Section 10.1(g12.12(i) HCM Expenses Cap Series B Shareholders Preamble Series C Repurchase Notice Section 8.7(b12.12(i) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Series C Shareholders Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Share Purchase Agreement Recitals Merger Recitals Merger Right Subpart F Income Section 3.1(a12.5 Subsidiary Board Section 10.1(ii) Modification in Recommendation US Subsidiary Preamble United States Shareholder Section 8.2(b12.5 Violation Section 5.1(i) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7WFOE Preamble

Other Defined Terms. Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii) The following terms shall have the meanings defined for such terms in the Sections set forth below: Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Business Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Exercise Period Section 10.1(e5.2 Company Unsubscribed Shares Section 5.2 Confidential Information Section 17.11 Co-Sale Holder Section 6.1 Co-Sale Notice Section 6.1 Defaulting Holder Section 12.4 Direct US Investor Section 17.10 Dispute Section 18.5(i) Domestic Company Expenses Overrun I Preamble Domestic Company II Preamble Domestic Company or Domestic Companies Preamble Drag Default Shares Section 8.7(b12.4 Drag-Along Holder Section 12.1 Drag-Along Notice Section 12.1 Drag-Along Sale Section 12.1(i) Drag-Along Sale Event Section 12.2 Dragged Holder Section 12.1 Effective Date Preamble Electing Participating Prior Preferred Holder Section 5.4(iv) Electing Participating Series E Preferred Holder Section 5.3(iv) ESOP Section 3.2(i) First Participation Notice Section 3.3(i) First Participation Period Section 3.3(i) Form F-3 Section 2.2(v) Founder I Preamble Founder II Preamble FounderCo or FounderCos Preamble FounderCo I Preamble FounderCo II Premable Holder Section 2.2(iv) Hong Kong Subsidiary Preamble HKIAC Section 18.5(i) Indirect US Investor Section 17.10(i) Initiating Holders Section 2.2(ii) Investor or Investors Preamble Investor Restricted Transfer Section 11.2 Investor Transferor Section 11.2 Investor Transfer Notice Section 11.3 Investor Transfer Shares Section 11.3 New Securities Section 3.2 Offered Price Section 5.1 Offered Shares Section 5.1 Offeror Section 12.1(i) Other Restriction Agreements Section 4.7 Participating Prior Preferred Holder Section 5.4(iv) Participating Series E Preferred Holder Section 5.3(iv) Party(ies) Preamble Permitted Transferee Section 8 PFIC Shareholder Section 17.10(i) PRC Company Indemnified Parties or PRC Companies Preamble Preemptive Right Section 6.8(a3.1 Prior Holder Exercise Period Section 5.4(i) Company Real Property Prior Holder Unsubscribed Shares Section 4.20(a5.4(iii) Company Registered Intellectual Property Prior Holder Pro Rata ROFR Share Section 4.21(a5.4(ii) Confidentiality Agreement Prior Holder ROFR Confirmation Notice Section 11.10 Constituent Companies 5.4(iii) Prior Preferred Holders Section 2.2(a5.3(v) Contributions Recitals Converted Warrant Prohibited Transfer Section 3.4 Corporate Records 9 Prospective Purchaser Section 4.7(a) D&O Indemnified Parties 5.1 Put Shares Section 6.8(a) Effective Time 9.1 Redemption Closing Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End 16.3 Redemption Date Section 10.1(h16.4 Registrable Securities Section 2.2(ii) Financial Statements Registrable Securities Then Outstanding Section 4.7(a)(ii2.2(iii) FTA Registration Section 4.15(y2.2(i) Government Contract Registration Expenses Section 4.29 HCM Preamble HCM Cure 2.2(vii) Remaining Shares Section 5.4(i) Repurchase Event Section 17.14(ii) Repurchase Right Section 17.14(ii) Request Notice Section 2.3(i) Restricted Business Section 17.8(i) Restricted Person Section 17.14(i) Residual Shares Section 6.1 Rights Holder Section 3.1 Right Participants Section 3.3(iii) ROFR Holder Section 5.1 Rules Section 18.5(i) SEC Section 2.2(vi) Second Notice Section 5.3(v) Second Participation Notice Section 3.3(ii) Series A Redemption Price Section 16.2(ii)(a) Series A to D Notice Date Section 16.2(i) Series A to D Participation Redeeming Holder Section 16.2(iii) Series A to D Redemption Notice Section 16.2(i) Series A to D Redemption Period Section 10.1(g16.2(iii) HCM Expenses Cap Series A to D Request Section 8.7(b16.2(i) HCM Expenses Overrun Series B Redemption Price Section 8.7(b16.2(ii)(b) HCM Financial Statements Series C Redemption Price Section 5.6(d16.2(ii)(c) HCM Indemnified Parties Series D Redemption Price Section 6.8(a16.2(ii)(d) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Series E Exercise Period Section 6.1 JOBS 5.3(i) Series E Notice Section 5.2 Series E Notice Date Section 16.1(i) Series E Unsubscribed Shares Section 5.3(iii) Series E Participation Redeeming Holder Section 16.2(iii) Series E Pro Rata ROFR Share Section 5.3(ii) Series E Redemption Notice Section 16.1(i) Series E Redemption Period Section 16.1(iii) Series E Redemption Price Section 16.1(ii) Series E Request Section 16.1(i) Series E ROFR Confirmation Notice Section 5.3(iii) Series E ROFR Notice Section 5.3(i) Series E Director Section 14.1(i)(b) Securities Act Section 5.6(a2.2(ix) K&S Security Holder Section 11.18(a17.2 Selling Expenses Section 2.2(viii) K&S Privileged Communications Subsequent Prior Holder Exercise Period Section 11.18(a5.4(iv) K&S Waiving Parties Subsequent Prior Holder Pro Rata Share Section 11.18(a5.4(iv) K&S WP Group Subsequent Series E Exercise Period Section 11.18(a5.3(iv) Legal Proceedings Subsequent Series E Pro Rata Share Section 4.10 Letter 5.3(iv) Super Right of Transmittal Participation Section 3.2(b3.3(i) Listing Application Tencent Schedule II Tencent Purchase Notice Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right 11.5 Tencent ROFR Period Section 3.1(a11.4 Third Participation Notice Section 3.3(iii) Modification in Recommendation Third Participation Period Section 8.2(b3.3(iii) Multiemployer Plan Transfer Notice Section 4.13(b5.1 Transferor Section 5.1 Tribunal Section 18.5(ii) Nasdaq Unredeemed Preferred Shares Section 4.4 New CayCo Preamble Offer Documents 16.4 Violation Section 8.2(a)(i2.9(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7WFOE Preamble

Other Defined Terms. For purposes of this Agreement, the following terms have the respective meanings set forth in the section referenced opposite such term: Term Location 2022 Audited Section 2016 Cedarhurst Financial Statement Section 6.14 Adjustments Section 3.1 Agreement Preamble Arcadian Cove Lessee Recitals Arcadian Cove Lessor Recitals Arcadian Cove Manager Recitals Arcadian Cove Net Lease Recitals Asset Acquisition Statement Section 3.4(b) Casualty Threshold Section 10.12 Cedarhurst Financial Statements Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Cash Contribution 6.14 Cedarhurst TRS Facility Master Tenant Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company 5.1 Effective Date Preamble Company Benefit Plan Escrow Agent Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality 3.2 Escrow Agreement Section 11.10 Constituent Companies 3.2 First Quarter 2017 Cedarhurst Financial Statement Section 2.2(a6.14 HIPAA Section 6.29(b) Contributions Holdco Interest Recitals Converted Warrant Holdco Purchaser Preamble Holdco Seller Preamble IDPH License Recitals Indemnification Cap Section 3.4 Corporate Records 8.3(a) Indemnified Party Section 8.4(a) Indemnifying Party Section 8.4(a) JV Membership Interests Recitals Loan Documents Section 6.23 Losses Section 8.1 Madison Ground Lessor Section 1.1 Material Contracts Section 6.7 Membership Interests Recitals OP Purchaser Preamble OP Seller Preamble Percentage Section 10.12 Permits and Licenses Section 6.9 Pxxxxx Center Consent and Assumption Agreement Section 1.1 Proration Date Section 3.3(a) Proration Schedule Section 3.3(a) Proxy Statement Section 4.6(a) Purchase Price Section 3.1 Purchaser Preamble Purchaser Indemnification Cap Section 8.3(b) Purchaser Parent Preamble Purchaser Threshold Section 8.3(b) Quad Cities SPEs Recitals Revised Statements Section 3.4(b) Scheduled Closing Date Section 5.1 SEC Section 4.6(a) Seller Preamble Seller Parent Preamble Seller Parent Change in Recommendation Section 4.7(a) D&O Indemnified Parties Seller Parent Change Notice Section 6.8(a4.8(d)(ii)(C) Effective Time Seller Parent Recommendation Section 2.4(b4.6(d) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Seller Parent Stockholder Meeting Section 8.2(b4.6(d) HoldCo Preamble Incentive Equity Plan Seller Threshold Section 6.10(a8.3(a) Individual Financial Statements SPE-level Property Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.72.2

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Number Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii7.4(ii) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Arbitration Notice Section 7.7 Cash Contribution Recitals 13.5(i) Breaching Party Section 13.10 BVI Company 1 Preamble BVI Company 2 Preamble BVI Company(ies) Preamble 11 Shareholders Agreement Cayman Companies Act Recitals Xxxxxxxx Chance Co Schedule I-A Chairman Section 11.18(b9.1(iv) Clifford Chance Privileged Communications Company Preamble Confidential Information Section 11.18(b12.6 (i) Clifford Chance Waiving Parties CRCM Schedule I-B Disclosing Party Section 11.18(b12.6 (iii) Clifford Chance WP Group Dispute Section 11.18(b13.5(i) Closing Dragged Shareholders Section 2.4(a11.1(ii) Closing Drag-Along Holders Section 11.1(i) Drag-Along Notice Section 11.3 Drag-Along Sale Section 11.1(i) Drag-Along Sale Date Section 2.4(a11.3 Exempt Registrations Section 3.4 First Participation Notice Section 7.4(i) Code Recitals Company Founder Preamble Company Benefit Founder Directors Section 9.1(i) Founder Investco Preamble GGV Capital Schedule I-B GGV Fund Schedule I-B Group Company(ies) Preamble HKIAC Section 13.5(ii) HKIAC Rules Section 13.5(ii) Hong Kong Holdco Schedule I-A IDG Schedule I-B Indemnification Agreement Section 9.8 Indemnified Person(s) Section 13.10 Interested Party Section 9.9 Interested Transaction Section 9.9 Investor(s) Preamble Investor Director(s) Section 9.1(i) Key Persons Incentive Plan Section 4.13(a12.8(i) Company Common Stock Key Persons Reserve Shares Section 4.5(a12.8 (i) Company Cure Period Key Person Shareholder Section 10.1(e12.8 (i) Company Expenses Overrun MFA Terms Section 8.7(b12.7(i) Company Indemnified Parties Morningside Schedule I-B Morningside Director Section 6.8(a9.1(i) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM New Securities Section 5.12(a7.3 Oversubscription Participants Section 7.4(ii) HCM Shareholders’ Meeting Section 8.2(bParty(ies) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Preemptive Right Section 3.1(a7.1 Preemptive Rights Holder Section 7.1 Principal Tribunal Section 13.5(ix)(1) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.712 Shareholders Agreement

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meaning defined for such terms in the Sections of this Lease set forth below: Accelerated Liability Section 6.3 2023 Financial Statements 21.3(c)(ii) Accepted Auditor Section 6.3 14.3(a) Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Tenant Cure Period Section 10.1(e21.5(a)(ii) Company Expenses Overrun Adjustment Section 8.7(b4.18(b) Company Indemnified Parties Adjustment Year Section 6.8(a4.3.1(c) Company Real Ad Valorem Tax Base Year Amount Section 9.1(d) Affiliate's S&RP Section 19.2 Alterations Section 16.1(a) Annual Audit Section 14.3(b) Anticipated Ensuing Fiscal Year Balance Section 19.7(g)(ii) Architect Section 12.2(a) Bankruptcy Court Recitals Big Six Firms Section 14.2(a) Capital Improvement Project Recitals Capital Replacements Account Section 19.7(a) CEC Recitals Change in Use Section 4.18(a) Change of Control Section 24.1(c) City Call Option Payment Section 4.3.1(b) City-Controlled Entity Section 32.4(d) City/Landlord Award Section 15.3 City Lease Amendment Section 1.21 City Payments Section 4.3 City Supplemental Payment Section 4.3.1(a) City Support Payment Period Section 4.3.1(c) Condemnation Section 15.1(a) Condemnation Escrow Account Section 15.4 20 Condemnation Escrow Agent Section 15.4 Condemnation Work Section 15.4 Conditions to Commencement of Construction Section 10.2(g) Construction Documents Section 10.2(j) Contingent Payments Section 4.6(a) CPI Fraction Section 4.3.1(c) CSDC Recitals Deadline Date Section 3.2 Discount Rate Section 21.3(j) Disputed Funds Section 21.1(g) Disputed Funds Escrow Account Section 21.1(g) Disputed Funds Escrow Agent Section 21.1(g) Donated Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality 4.14 Effective Date Recitals Eldorado Recitals Eldorado Subsidiary Recitals Eldorado Merger Transaction Recitals Enterprise Services Agreement Section 11.10 Constituent Companies 1.40 Environmental Matters Section 2.2(a18.2 Equivalent Payments Section 6.6(f)(ii) Contributions Recitals Converted Warrant Excess Section 3.4 Corporate Records 21.3(b)(i) Excess Proceeds Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a23.3(c) Exchange Agent Act Section 3.2(a1.103 Fair Rental Value Section 7.1(c) Expenses Cap Final Completion Delay Section 8.7(b) Export Approvals Section 4.26(a) Extended End 1.44 First Amended and Restated Lease Recitals First Installment Date Section 10.1(h4.3.1(b)(i)(A) Financial Statements First Leasehold Mortgagee Section 4.7(a)(ii6.6(d) FTA First Subleasehold Mortgagee Section 4.15(y6.6(d) Government Contract Force Majeure Event Section 4.29 HCM 32.2(a) Full Fiscal Year Section 1.50 Gaming Percentage Statement Section 4.2(b) Gross Gaming Payments Section 4.2 Gross Gaming Percentage Amount Section 4.2(a) Gross Non-Gaming Payments Section 4.7 Xxxxxx'x Jazz Company Preamble HCM Hotel Opening Delay Section 1.62 House Bank Account Section 19.5 ICS Section 19.12(a) ICS Audit Report Section 19.12(b) ICS Regulation Section 19.12(b) Impositions Section 9.1(a) Invested Capital Section 24.1(e) JCC Equity Program Section 5.1 JCC S&RP Section 19.2 Landlord's Audit Section 14.3(b) Landlord Lease Option Section 7.1(a) Legislation Recitals Legislative Payments Section 4.3.1 Liens Section 10.3(a) Local Firm Section 14.3(a) LO Term Section 7.1(c) Major Condemnation Section 15.1(b) Marks Section 5.3(d) Merger Agreement Recitals Minimum Payments Section 4.17 Minimum Payment Amount Section 4.17 Minor Condemnation Section 15.1(c) Monthly Reports Section 14.2(b) New Lease Section 23.6 Nominee Section 23.3(a) Non-Gaming Minimum Payment Section 4.7(b) Non-Gaming Percentage Payment Section 4.7(c) Non-Gaming Percentage Statement Section 4.7(d) Non-Structural Alteration Section 16.1(d) Notice of Termination Section 21.3 Option Period Section 6.6(e) Original Amended Lease Recitals Original Lease Recitals Other Operator Section 6.6(d) Plan Recitals Plan Effective Date Recitals Possession Date Section 6.3 Preliminary Termination Notice Section 21.5(a)(ii) Preservation Costs Section 19.5 Proceeds Section 15.1(d) Profit Section 24.1(e) Project Budget Section 10.2(l) Property Management Agreement Section 1.40 Property/Casualty Insurance Section 13.1(a) Qualified Appraiser Section 4.18(c) Qualified Net Worth Section 22.2 RDC Recitals Re-letting Expenses Section 21.3(b)(ii) Rental Adjustment Date Section 4.1 Repair Work Section 12.2(a) Replacement Casino Section 6.6(f)(ii) Replacement Subtenant Section 21.5(a)(ii) Replacement VICI Sublease Section 21.5(a)(ii) Required Policy Section 13.13 Requiring Party Section 13.13 Residency Requirement Section 5.2(a) Restoration Account Section 19.7(i) Riverboat Casino Section 8.4 School Support Payments Section 4.5 Second Audit Section 14.3(b) Second Floor Rent Section 4.11(a) Secured Areas Section 17.2 Secured Obligations Section 6.6(d) Special Event Charges Section 9.7 SSD Cure Period Section 10.1(g21.5(a)(ii) HCM Expenses Cap Sublease Secured Obligations Section 8.7(b6.6(d) HCM Expenses Overrun Subtenant Obligations Section 8.7(b32.25 Subtenant Specific Default Section 21.5(ii) HCM Financial Statements Tenant Award Section 5.6(d15.3 Tenant's Notice Section 5.3(d) HCM Indemnified Parties Third Party Environmental Matters Section 6.8(a18.3 TPO Price Section 7.1(b) HCM SEC Filings Tenant Purchase Option Section 5.5 HCM Securities 7.1(a) TPO Term Section 5.12(a7.1(b) HCM Shareholders’ Meeting Transfer Section 8.2(b24.1(a) HoldCo Preamble Incentive Equity Plan Transferee Section 6.10(a24.1(c) Individual Financial Statements Transferor Section 4.7(a)(ii24.1(e) Intended Tax Treatment Recitals Interim Transfer Payment Section 24.1(e) Transition Fund Section 19.5 Transition Period Section 6.1 JOBS Act 19.5 Uncured Event of Default Section 5.6(a21.3(a) K&S Uncured Subtenant Specific Default Section 11.18(a) K&S Privileged Communications 21.5 VICI Recitals VICI REIT Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.724.1(b)(xi)

Other Defined Terms. Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii) Agreement Preamble Ancillary Agreements Approved Industrial Adhesives Section 11.10 Authorization 5.7(a) Arbitration Proceedings Section 7.5 Cash Adjustment Notification Date Section 2.18(a) Cash Transfer Section 2.14(a) CEO Negotiation Request Section 7.3 Chosen Courts Section 10.2(b) control Definition of Affiliate Copyrights Definition of Intellectual Property Rights Covered Policies Section 5.1(b) CPR Section 7.4 D&O Policies Section 5.5 Delayed Parent Asset Section 2.4(h) Delayed Parent Liability Section 2.4(h) Confidential Treatment Requested by 3M Health Care Company Pursuant to 17 C.F.R. Section 200.83 Delayed SpinCo Asset Section 2.4(c) Delayed SpinCo Liability Section 2.4(c) Delayed Transferred Assets Section 2.11 Delayed Transferred Parent Asset Section 2.11 Delayed Transferred SpinCo Asset Section 2.10 Dispositions Recitals Dispute Section 7.1 Distribution Recitals e-mail Section 10.5 Government Investigation Section 4.11(e) Indemnifying Party Section 4.4(a) Indemnitee Section 4.4(a) Indemnity Payment Section 4.4(a) Initial Notice Section 7.7 7.1 Internet Property Rights Definition of Intellectual Property Rights Joint Actions Section 4.11(c) Legal Holds Section 6.5 Managing Party Section 4.11(d) Mediation Request Section 7.4 Misallocated Asset Section 2.1(c) Misallocated Liability Section 2.1(c) Non-Managing Party Section 4.11(d) Officer Negotiation Request Section 7.2 Parent Preamble Parent Accounts Section 2.9(a) Parent Assets Section 2.2(b) Parent Board Recitals Parent Directed Actions Section 4.11(b)(i) Parent Indemnitees Section 4.2 Parent Liabilities Section 2.3(b) Parent Restricted Employees Section 5.6(a) PFAS Products Section 5.7(e) Post-Separation Effective Times Section 2.19 Post-Separation Transferred Assets and Liabilities Section 2.19 Procedure Section 7.4 Retained Stock Recitals SEC Recitals Separation Recitals Separation Step Plan Section 2.1(a) Specified Ancillary Agreement Section 10.18(b) SpinCo Preamble Confidential Treatment Requested by 3M Health Care Company Pursuant to 17 C.F.R. Section 200.83 SpinCo Accounts Section 2.9(a) SpinCo Assets Section 2.2(a) SpinCo Cash Section 2.2(a)(ii) SpinCo Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance SpinCo Directed Actions Section 11.18(b4.11(a)(i) Clifford Chance Privileged Communications SpinCo Financing Arrangements Section 11.18(b2.14(a) Clifford Chance Waiving Parties SpinCo Indemnitees Section 11.18(b4.3 SpinCo Liabilities Section 2.3(a) Clifford Chance WP Group SpinCo Restricted Employees Section 11.18(b5.6(b) Closing Straddle Period Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock 2.15 Third-Party Claim Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Trade Secrets Definition of Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter Rights Trademarks Definition of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Intellectual Property Rights Transfer Documents Section 8.2(a)(i2.1(b) Other Indemnitors Transition Committee Section 6.8(e2.16 Unreleased Parent Liability Section 2.5(b)(ii) Parties Preamble Party Preamble Personal Information Laws and Policies Unreleased SpinCo Liability Section 4.22(a2.5(a)(ii) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7ARTICLE II THE SEPARATION

Other Defined Terms. Other capitalized terms used herein are defined elsewhere in this Agreement. Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Agreement Introduction Alternative Proposal Section 6.3 Additional Deposit Amount 7.9.1 Alternative Transaction Section 7.6 Affiliate Agreements 7.9.1 Articles of Merger Section 4.12(a)(vii) 2.2 Banking Code Section 2.1 Bank Merger Preamble Berkshire Bank Introduction Berkshire Bank Articles Section 5.1.3 Berkshire Bank Bylaws Section 5.1.3 Berkshire Bancorp Introduction Berkshire Bancorp Articles Section 5.1.2 Berkshire Bancorp Bylaws Section 5.1.2 Berkshire Bancorp Disclosure Schedule Article 5 Berkshire Bancorp Ratio Section 9.1.7 Berkshire Bancorp Regulatory Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice 5.5.2 Berkshire Bancorp Requisite Regulatory Approvals Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance 8.2.3 Berkshire Bancorp Stock Plans Section 11.18(b) Clifford Chance Privileged Communications 5.2.1 Berkshire Bancorp Subsidiary Section 11.18(b) Clifford Chance Waiving Parties 5.1.3 Berkshire Bancorp Warrants Section 11.18(b) Clifford Chance WP Group 3.1.6 Berkshire Contract Section 11.18(b) 5.13.1 Berkshire Director Designee Section 7.11 Berkshire Tarp Shares Section 5.2.1 Berkshire Tarp Shares Series A Section 5.2.1 Berkshire Tarp Shares Series B Section 5.2.1 Claim Section 7.6.1 Closing Section 2.4(a) 10.1 Closing Date Section 2.4(a10.1 Code Preamble Confidentiality Agreement Section 7.3.3 Covered Employees Section 7.5.1 Departing Berkshire Directors Section 7.11 Derivative Transactions Section 4.14.1 DPC Common Shares Section 3.12 Effective Time Section 2.2 Election Section 3.2.1(a) Code Recitals Election Deadline Section 3.2.1(d) Term Section Environmental Laws Section 4.18 ERISA Section 4.11.1 ERISA Affiliate Section 4.11.3(d) Exchange Agent Agreement Section 3.2.1(d) Exchange Fund Section 3.2.2 Expense Reimbursement Section 9.3.2(c) FDIC Section 4.1.4 Federal Reserve Board Section 4.4 Form of Election Section 3.2.1(b) GAAP Section 5.1.3 Governmental Entity Section 4.4 Holdco Introduction Holder Section 3.2.1 Holding Company Reorganization Preamble Company Benefit Plan HSR Act Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company 4.4 Indemnified Parties Section 6.8(a) Company Real Property 7.6.1 Index Price Section 4.20(a) Company Registered 9.1.7 Index Ration Section 9.1.7 Injunction Section 8.1.3 Insurance Amount Section 7.6.2 Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 4.17 Letter of Transmittal Section 3.2(b3.2.3(a) Listing Application Loan(s) Section 6.7 Lock-Up 4.25.1 Materially Burdensome Regulatory Condition Section 7.2 Merger Preamble Merger Consideration Section 3.1.3 NCB Introduction NCB Articles Section 4.1.2 NCB Board Section 4.3.1 NCB Bylaws Section 4.1.2 NCB Contract Section 4.13.1 NCB Directors Section 7.11 NCB Disclosure Schedule Article 4 NCB Regulatory Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation 4.5.2 NCB Requisite Regulatory Approvals Section 8.2(b) Multiemployer Plan 8.3.3 NCB Shareholder Meeting Section 4.13(b) Nasdaq 7.4.1 Other Regulatory Approvals Section 4.4 New CayCo Pending NCB Registration Statement Preamble Offer Documents Permitted Encumbrances Section 8.2(a)(i) Other Indemnitors 4.16 Personal Property Lease Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws 4.19 Plans Section 4.11.1 Policies, Practices and Policies Procedures Section 4.22(a) Processors Section 4.22(a) 4.15.2 Proxy Statement-Prospectus Section 11.1 Proxy Statement 7.1.1 Public Proposal Section 8.2(a)(i9.3.2(b) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii4.16 Term Section Regulatory Agencies Section 4.5.1 Resulting Institution Preamble SEC Section 4.4 Securities Act Section 4.2.1 Shortfall Number Section 3.1.6(b)(ii) Registrar Stock Consideration Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities 3.1.3 Subsidiary Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation 5.1.3 Support Agreements Preamble Termination Fee Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) 9.3.2 Trust Account Common Shares Section 11.1 Trust Agreement 3.12 Voting Debt Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.74.2.1

Other Defined Terms. Term Location 2022 Terms Section Acquiror Preamble Acquiror Class B Holder Consent 5.2(a) Acquiror Cure Period 10.1(g) Acquiror Debt Transactions 8.5 Acquiror Disclosure Letter Article V Acquiror Expense Reimbursement 10.3(d) Acquiror Fairness Opinion 9.1(i) Acquiror Financial Statements 5.6(c) Acquiror Indemnified Parties 7.8(a) Acquiror Intervening Event 8.2(b)(ii) Acquiror Intervening Event Notice 8.2(b)(ii) Acquiror Intervening Event Notice Period 8.2(b)(ii) Acquiror Option 3.3(a) Acquiror PIPE Investment 8.5 Acquiror PIPE Investor 8.5 Acquiror Restricted Stock 3.3(b) Acquiror SEC Filings 5.5 Acquiror Securities 5.12(a) Acquiror Shareholders’ Meeting 8.2(b) Acquiror Stock Warrant 3.3(a) Acquiror Termination Payment 10.3(b) Additional Audited Financial Statements Section 6.3 2023 Additional Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Required Financial Statements 6.3 Additional Transactions 8.5 Additional Unaudited Financial Statements 6.3 Affiliate Agreements Section 4.12(a)(vii4.10(a)(xi) Agreement Preamble Agreement End Date 10.1(e) Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Carlyle Consent 6.7 Closing Section 2.4(a2.3(a) Closing Date Section 2.4(a2.3(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a4.4(a) Company Consolidated Group 4.20(e) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(bDisclosure Letter Article IV Company Expense Reimbursement 10.3(c) Company Financial Statements 4.6(a) Company Indemnified Parties Section 6.8(a7.8(a) Company Real Insurance Policies 4.14 Company Intellectual Property Section 4.20(a1.1 Company Material Contracts 4.10(a) Company Material Customers 4.11(a) Company Material Vendors 4.11(b) Company Preferred Stock 4.4(a) Company Qualified Benefit Plan 4.18(b) Company Registered Intellectual Property 4.13(a) Company Registered IP 4.13(a) Company Series D-4 Preferred Stock 4.4(a) Company Series D-5 Preferred Stock 4.4(a) Company Series D-6 Preferred Stock 4.4(a) 15 Terms Section 4.21(aCompany Series D-7 Preferred Stock 4.4(a) Company Series D-8 Preferred Stock 4.4(a) Company Software 4.13(a) Company Termination Payment 10.3(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(aCorporations 2.1(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(aConstituent Entities 2.1(c) Continental 5.8 Cooley 11.18(a) Cooley Privileged Communications 11.18(a) Cooley Waiving Parties 11.18(a) Xxxxxx XX Group 11.18(a) D&O Indemnified Parties Section 6.8(a7.8(a) DGCL Recitals Dissenting Shares 3.5 Domesticated Acquiror Certificate of Incorporation 7.7 Domesticated Acquiror Common Stock Recitals Domestication Recitals Effective Time Section 2.4(b2.3(b) ERISA Section 4.13(a4.18(b) ESPP 7.1(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(bExchange Agent Termination Date 3.2(a) Export Approvals Section 4.26(aExpense Reimbursements 10.3(d) Extended End Date Section 10.1(hExtension Meeting 8.7(d) Extension Proposal 8.7(a) Extension Proxy Statement 8.7(a) Financial Statements Section 4.7(a)(ii4.6(a) FTA Section 4.15(yFirst Effective Time 2.3(b) Government Contract Section 4.29 HCM First Merger Certificate 2.1(a) First Merger Sub Preamble HCM Cure Period Section 10.1(gFirst Sponsor Designee 7.6(a) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Governmental Approval 4.5 Incentive Equity Plan Section 6.10(a7.1(a) Individual Financial Statements Section 4.7(a)(iiIndependent Director 7.6(a) Intended Tax Treatment Initial Constituent Corporations 2.1(a) Initial Surviving Corporation Recitals Interim Period Section 6.1 Interim Unaudited Company Financial Statements 4.6(a) Interim Unaudited Solaria Financial Statements 4.6(a) JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Liabilities 4.8(a) Listing Application 7.3 Terms Section 6.7 Lock-Up Agreement Recitals Merger Certificate 2.1(a) Mergers Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(bNYSE 5.6(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e7.8(e) Owned Land 4.12(b) Xxxx Xxxxxxxx 11.18(b) Xxxx Xxxxxxxx Privileged Communications 11.18(b) Xxxx Xxxxxxxx Waiving Parties Preamble Party Preamble 11.18(b) Xxxx Xxxxxxxx WP Group 11.18(b) Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) 4.16 Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b4.12(c) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller SCI Consent 6.8 Second Effective Time 2.3(b) Second Merger Certificate 2.1(c) Second Merger Sub Preamble Sponsor Parties Recitals Surviving Company Recitals Solaria Financial Statements 4.6(a) Solaria Series D Preferred Stock 4.4(a) Subscription Agreement 8.5 Tangible Assets 4.12(a) Terminating Acquiror Breach 10.1(g) Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(aTermination Payments 10.3(b) Transaction Litigation Section 8.6 7.10 Transaction Proposals Section 8.2(b) Treasury Share 3.1(a) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7U.S. Tax Treatment 2.7(a) Unaudited Company Financial Statements 4.6(a) Unaudited Solaria Financial Statements 4.6(a)

Other Defined Terms. In addition, the following terms shall have the meanings ascribed to them in the corresponding section of this Agreement: Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Agreement Preamble Approved Budget Section 6.3 Additional Deposit 2.5(c) Approved Indebtedness Section 2.5(n) Board Recitals Buyout Notice Section 3.3(a) Company Preamble Director Section 2.1(a) Drag Third Party Purchaser Section 3.3(a) Drag-Along Outside Date Section 3.3(b) Drag-Along Sale Section 3.3(a) Dragging Investor Section 3.3(a) Election Period Section 4.2 Funding Event Amount Section 7.6 Affiliate Agreements 4.9 Funding Event Shortfall Section 4.12(a)(vii4.9 Initial Board Section 2.1(a) Agreement Preamble Ancillary Agreements Initial Funded Portion Section 11.10 Authorization 4.9 Initial Rescue Funding Event Section 4.9 IPO Triggering Person Section 3.8 Issuance Section 4.3 New Debt or Equity Interests Section 4.1 Non-Rescue Investors Section 4.9 Notice of Acceptance Section 4.4 Optional Rescue Funding Notice Section 7.7 Cash Contribution 4.9 Participating Tag-Along Rightholder Section 3.2(b) Parties Preamble Plan Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Preemptive Offer Notice Section 11.18(b4.2 Preemptive Right Section 4.1 Preemptive Rights Holder Section 4.1 Proportionate Percentage Section 4.1 Proposed ROFO Transfer Section 3.4 Proposed Transfer Section 3.2(b) Clifford Chance Privileged Communications Public Entity Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality 3.8 Registration Rights Agreement Section 11.10 Constituent Companies 7.1(a) Related Party Transaction Section 2.2(a2.5(g) Contributions Recitals Converted Warrant Remaining Portion Section 4.9 Removal Request Section 2.1(d) Reorganization Section 3.8 Rescue Event Section 4.9 Rescue Financing Section 4.9 Rescue Investor Section 4.9 ROFO Acceptance Notice Section 3.4 Corporate Records ROFO Holders Section 4.7(a) D&O Indemnified Parties 3.4 ROFO Notice Section 6.8(a) Effective Time 3.4 ROFO Offer Section 2.4(b) ERISA 3.4 ROFO Offer Price Section 4.13(a) Exchange Agent 3.4 ROFO Offered Shares Section 3.4 Selling ROFO Investor Section 3.4 Selling Tag Investor Section 3.2(a) Expenses Cap Subject Purchaser Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal 4.1 Tag-Along Notice Section 3.2(b) Listing Application Tag-Along Notice Period Section 6.7 Lock3.2(b) Tag-Up Agreement Recitals Merger Recitals Merger Right Along Rightholder Section 3.1(a3.2(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Winning ROFO Investor Section 3.4 Warrant Exchange Winning ROFO Offer Section 3.4 Written Objection Section 7.73.4

Other Defined Terms. The following terms shall have the meanings defined for such terms in the Sections set forth below: Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Action Section 6.3 Additional Deposit Amount 8.1 Adverse Disclosure Section 5.1(b) Applicable Shares Section 10.1(a) Automatic Shelf Registration Statement Section 5.1(b) Blue Spectrum Holder Section 5.1(a) Buyer Recitals Call Right Section 10.1(a) Xxxxxxx Xxxxxx Section 5.1(c) Carlyle Nominee Section 2.1(c)(i) Carlyle VI Preamble Cause Section 10.7(a) Code Section 10.7(b) Company Preamble Consultant Section 10.7(c) Corporate Entity Section 7.6 Affiliate Agreements CP VI Coinvestment A Preamble CP VI Coinvestment B Preamble CP VI Holdings Preamble Demand Delay Section 4.12(a)(vii5.3(a)(ii) Agreement Preamble Ancillary Agreements Demand Holder Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b5.3(a) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Demand Period Section 10.1(e5.3(c) Company Expenses Overrun Demand Registration Section 8.7(b5.3(a) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) 12 Effective Time Section 2.4(b11.19 Eligible Tag-Along Stockholder Section 4.4(a) ERISA Eligible Take-Down Holder Section 4.13(a5.1(e) Exchange Agent Employee Section 3.2(a10.7(d) Expenses Cap Employee Equity Arrangement Section 8.7(b7.1 Financial Investor Holder Section 5.1(f) Export Approvals GIC Holder Section 4.26(a5.1(g) Extended End Date H&F Holder Section 10.1(h5.1(f) Financial Statements H&F Nominee Section 4.7(a)(ii2.1(c)(i) FTA HFCP VII Preamble HFCP VII Executives Preamble HFCP VII Parallel Preamble HFCP VII Parallel-A Preamble HFCP VIII Preamble HFCP VIII Associates Preamble HFCP VIII Executives Preamble HFCP VIII Parallel Preamble HFCP VIII Parallel-A Preamble Holder Section 4.15(y5.1(i) Government Contract Holders Section 4.29 HCM 5.1(i) Holdings Recitals Indemnification Sources Section 8.2 Indemnified Liabilities Section 8.1 Indemnified Party Section 5.7(c) Indemnifying Party Section 5.7(c) Indemnitee-Related Entities Section 8.2 Indemnitees Section 8.1 Initial Blue Spectrum Entities Preamble HCM Cure Period Initial Carlyle Entities Preamble Initial GIC Entities Preamble Initial H&F Entities Preamble In-Kind Distribution Section 10.1(g4.1(f) HCM Expenses Cap Jaguar I Recitals Joinder Agreement Section 8.7(b4.1(d) HCM Expenses Overrun Jointly Indemnifiable Claims Section 8.7(b8.2 Litigation Section 11.8(a) HCM Financial Statements Manager Group Representative Section 5.6(d11.14 Manager Side Agreements Section 3.1(e) HCM Indemnified Parties Marketed Take-Down Notice Section 6.8(a5.2(d)(iii) HCM SEC Filings Marketed Underwritten Shelf Take-Down Section 5.5 HCM Securities Section 5.12(a5.2(d)(iii) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Merger Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Merger Agreement Recitals Merger Sub Recitals Merger Right Offer Shares Section 3.1(a4.4(a) Modification in Recommendation Parent Stockholder Section 8.2(b1.3(d) Multiemployer Plan Participation Subsidiaries Section 4.13(b7.5 Pre-Closing H&F Entities Preamble Prior Agreement Recitals Pro Rata Take-Down Share Section 5.2(d)(ii)(C)(1) Nasdaq Proposed Transferee Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a4.4(a) Prospectus Section 11.1 Proxy Statement 5.1(j) Record Holder Stockholder Section 8.2(a)(i1.3(d) Proxy Statement/register Section 5.1(k) registered Section 5.1(k) Registrable Securities Section 5.1(l) registration Section 5.1(k) Registration Expenses Section 5.1(m) Registration Statement Section 8.2(a)(i5.1(k) PubCo Preamble PubCo Reorganization Merger Recitals Q3 Financial Statements Repurchase Note Section 6.3 Real Property Leases 10.4 Repurchase Period Section 4.20(b)(iii10.1(a) Registrar Repurchase Price Section 2.4(b10.3 Restricted Shelf Take-Down Section 5.2(d)(ii)(A) Registration Rights Agreement Recitals Restricted Shelf Take-Down Notice Section 5.2(d)(ii)(A) Restricted Take-Down Participation Notice Section 5.2(d)(ii)(B) Restricted Take-Down Selling Holders Section 5.2(d)(ii)(A) Sale Notice Section 4.4(a) Service Provider Section 10.7(e) Shelf Holder Section 5.2(a) Shelf Percentage Section 5.1(n) Shelf Period Section 5.2(b) Shelf Registration Statement Securities Section 8.2(a)(i5.1(o) Reorganization Recitals Reorganization Documentation Shelf Suspension Section 6.6 Seller Preamble 5.2(c) Shelf Take-Down Section 5.1(p) Shelf Take-Down Percentage Section 5.2(d)(ii)(A) Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Holder Section 10.1(e5.1(q) Terminating HCM Breach Spousal Consent Section 10.1(g3.2(g) Title IV Plan Stockholder Sellers Section 4.13(b4.4(a) Top Vendors Tag-Along Right Section 4.28(a4.4(c)(i) Transaction Litigation Tag-Along Sale Period Section 8.6 Transaction Proposals 4.4(c)(i) Tag-Along Sellers Section 8.2(b4.4(b) Trust Account Tag-Along Shares Section 11.1 Trust Agreement 4.4(b) Tag-Along Stockholder Section 5.8 Trustee 4.4(b) Take-Down Tagging Holders Section 5.8 Warrant Assumption Agreement 5.2(d)(ii)(A) Termination of Service Section 3.4 Warrant Exchange 10.7(f) Third Party Holder Section 3.4 Written Objection 5.1(r) Third Party Shelf Holder Section 7.75.2(a) Well-Known Seasoned Issuer Section 5.1(s)

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Number Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii7.4(b) Agreement Preamble Ancillary Agreements Appointing Shareholder(s) Section 11.10 Authorization 9.2(b) Approving Holders Section 12.10 Arbitration Notice Section 7.7 Cash Contribution 13.5(a) Business Recitals Cayman Companies Act Recitals Xxxxxxxx Chance CEO Section 11.18(b11.1(a) Clifford Chance Privileged Communications CFC Section 11.18(b12.7(d) Clifford Chance Waiving Parties CFO Section 11.18(b11.2 Chairman Section 9.1(a) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Confidential Information Section 12.13(a) Didi Director Section 9.1(a) Didi Director Veto Matters Section 10.2(e) Didi Observer Section 9.4 Direct US Investor Section 12.7(c) Dispute Section 13.5(a) Domestic Company Benefit Preamble Effective Date Preamble ESOP Section 12.9(a) ESOP Plan Section 4.13(a12.9(d) Company Common Stock ESOP Shares Section 4.5(a12.9(a) Company Cure Exempt Registrations Section 3.4 Exercise Price Section 12.9(b) First Participation Notice Section 7.4(a) First Participation Period Section 10.1(e7.4(a) HKIAC Section 13.5(b) HKIAC Rules Section 13.5(b) HK Company Expenses Overrun Preamble Incentive Employees Section 8.7(b12.9(a) Company Indemnified Parties Indirect US Investor Section 6.8(a12.7(c) Company Real Property Investor(s) Preamble Investor Director(s) Section 4.20(a9.1(a) Company Registered Intellectual Property Losses Section 4.21(a12.5(a) Confidentiality New Securities Section 7.3 Observer(s) Section 9.4 Ordinary Directors Section 9.1(a) Oversubscription Participants Section 7.4(b) Partnership(s) Preamble Participation Notice Section 7.4 (b) Party(ies) Preamble PFIC Section 12.7(c) PFIC Shareholder Section 12.7(c) Preemptive Right Section 7.1 Preemptive Rights Holder Section 7.1 Principal(s) Preamble Principal Holding Company(ies) Preamble Prior Agreement Preamble Pro Rata Share Section 11.10 Constituent Companies 7.2 PV Observer Section 2.2(a9.4 Representatives Section 12.13(b) Contributions Recitals Converted Warrant Restricted Business Section 3.4 Corporate Records 12.3(a) Second Participation Notice Section 4.7(a7.4(b) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Second Participation Period Section 10.1(g7.4(b) HCM Expenses Cap Security Holder Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment 12.16 Series C Purchase Agreement Recitals Interim Services Period Section 6.1 JOBS Act 12.3(b) Subsidiary Board Section 5.6(a9.1(b) K&S Taikang Director Section 11.18(a9.1(a) K&S Privileged Communications TK Director Veto Matters Section 11.18(a10.2(c) K&S Waiving Parties Tencent Director Section 11.18(a9.1(a) K&S Tencent Director Veto Matters Section 10.2(d) Trade Sale Section 12.10 Vacancy Period Section 9.2(b) Violation Section 5.1(a) WFOE Preamble WP Group Director Section 11.18(a9.1(a) Legal Proceedings WP Director Veto Matters Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.710.2(b)

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below Additional Number Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii7.5(ii) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Business Recitals Company Preamble Co-Sale Notice Section 11.1 Co-Sale Shares Section 11.1 Deed of Adherence Section 7.8 Disposal Section 8.3(i) Shareholders Agreement 9 Dispute Section 18.6(i) Domestic Company Benefit Plan Preamble Dong SPV Preamble Drag Transaction Section 4.13(a10.1 Drag Notice Section 10.1 Drag-Along Transferors Section 10.1 ESOP Section 7.4(ii) Exempt Registrations Section 3.4 Exercising Shareholder Section 9.2(ii) Financing Terms Section 17.12(i) First Participation Notice Section 7.5(i) High Vote Holders Section 8.3(i) High Vote Shares Section 17.13(i) High Voting Rights Section 17.13(ii) HK Company Common Stock Preamble HKIAC Section 4.5(a18.6(i) Company Cure Investment Policy Section 16.1(viii) Investor Preamble Low Vote Shares Section 17.13(i) Li SPV Preamble Management SPV Preamble Money Laundering Laws Section 17.6(i) Mx. Xxxx Preamble Mx. Xx Preamble New Offering Section 8.9(ii) New Securities Section 7.4 Non-Transferring Parties Section 10.1 Observer Section 15.2 Offered Shares Section 9.1(i) Option Period Section 10.1(e9.2(i)(a) Company Expenses Overrun Oversubscription Participants Section 8.7(b7.5(ii) Company Indemnified Parties Party Preamble Permitted Transferee Section 6.8(a12.4 PFIC Shareholder Section 17.5(iii) Company Real Property Preemptive Pro Rata Share Section 4.20(a) Company Registered Intellectual Property 7.3 Preemptive Right Section 4.21(a) Confidentiality 7.1 Prior Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Prior Subscription Agreement Recitals Purchase Right Period Section 10.1(g8.9(i) HCM Expenses Cap Qualified Financing Section 8.7(b8.9(iii) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Restraint Period Section 6.1 JOBS Act 17.9 Restricted Business Section 5.6(a17.9 Rights Holder Section 7.1 Second Notice Section 9.2(ii) K&S Second Participation Notice Section 11.18(a7.5(ii) K&S Privileged Communications Second Participation Period Section 11.18(a7.5(ii) K&S Waiving Parties Security Holder Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up 17.2 Signing Date Preamble Subscription Agreement Recitals Merger Recitals Merger Right Transferor Section 3.1(a9.1(i) Modification in Recommendation Transfer Notice Section 8.2(b9.1(i) Multiemployer Plan Violation Section 4.13(b5.1(i) Nasdaq Section 4.4 New CayCo WFOE Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties YY Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Shareholders Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.710

Other Defined Terms. The following terms shall have the meanings defined for such terms in the Sections set forth below: Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Section 6.3 10% ESOP Quota 19.16 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(viiNumber 7.4(b) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Alternative Plan 19.11(b) Arbitration Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b20.6(a) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Business Recitals Company Preamble Confidential Information 19.10(a) Co-Sale Notice 10.1 Dian Guan Preamble Dispute 20.6(a) Domestic Companies Preamble Drag Holders 15.1 Drag-Along Notice 15.1 Drag-Along Sale 15.1 Dragged Holders 15.1 Effective Date Preamble Exempt Registrations 3.4 Exercising Shareholder 9.2(c) First Participation Notice 7.4(a) First Participation Period 7.4(a) HK Company Benefit Plan Section 4.13(aPreamble HKIAC 20.6(b) Company Common Stock Section 4.5(aHKIAC Rules 20.6(b) Company Cure Investor’s Partners 19.15 Jifen Preamble New ESOP 18.1(f) New ESOP Anti-dilution Right 19.16 New Securities 7.3 Observer 17.1 Offered Shares 9.1 Offeror 15.1 Option Period Section 10.1(e9.2(a) Company Expenses Overrun Section 8.7(bOrdinary Director 17.1 Ordinary Shareholder Preamble Oversubscription Participants 7.4(b) Company Indemnified Parties Section 6.8(aParticipation Notice 7.4(b) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Participation Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e7.4(b) Parties Preamble Party Preamble Personal Information Laws and Policies Permitted Transferee 12.1 Permitted Transferees 12.1 Preemptive Pro Rata Share 7.2 12 Shareholders’ Agreement Term Section 4.22(aPreemptive Right 7.1 Principal Preamble Principal Holding Companies Preamble Principal Holding Company Preamble Principals Preamble Prohibited Transfer 13.1 Put Consideration 19.17(a) Processors Section 4.22(aPut Notice 19.17(b) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(iPut Right 19.17(a) Proxy Statement/Qukandian Preamble Re-allotment Period 9.2(c) Restricted Business 19.8 ROFR Pro Rata Share 9.2(b) Second Notice 9.2(c) Second Participation Notice 7.4(b) Second Participation Period 7.4(b) Selling Shareholder 10.1 Series A Director 17.1 Series A Investor Preamble Series A Investors Preamble Series A Share Purchase Agreement Recitals Series A Shareholders Agreement Recitals Series A1 Investor Preamble Series A1 Share Purchase Agreement Recitals Series A1 Shareholders Agreement Recitals Series B1 Director 17.1 Series B1 Investor Preamble Series B1 Share Purchase Agreement Recitals Series B2 Investors Preamble Series B2 Share Purchase Agreement Recitals Series B3 Investors Preamble Series B3 Share Purchase Agreement Recitals Shelf Period 2.2(a) Shelf Registration Statement 2.2 Shelf Takedown Request 2.2(b) Subpart F Income 19.15 Tokens 19.18 Transfer 8.1 Transfer Notice 9.1 Transferor 9.1 Tuile Preamble VIE Event 19.11(b) Violation 5.1(a) WFOE Preamble 13 Shareholders’ Agreement Term Section 8.2(a)(i) PubCo Xike Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7Zhangduan Preamble

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Acceptance Period Section 6.3 2023 Financial Statements 8.2(b) Additional Investor Offered Equity Securities Section 6.3 8.3(d) Additional Deposit Amount Offered Equity Securities Section 7.6 Affiliate Agreements 8.2(d) Additional Quantity Section 4.12(a)(vii7.3(c) Agreement Preamble Ancillary Agreements Ali Preamble Baozun Preamble Business Section 11.10 Authorization 13.1(a)(i) CFC Section 15.9 Code Section 15.9 Company Preamble Crescent Preamble Demand Registration Section 2.1 Disclosing Party Section 14.4 Disposing Investor Section 8.3(a) Disposing Party Section 8.2(a) Dispute Section 16.3 Drag-along Amount Section 8.4(a) Exempt Registrations Section 3.4 Extended Investor Acceptance Period Section 8.3(d) Exercising Investor Section 8.3(f) Exercising Party of Right of First Refusal Section 8.3(d) Financing Terms Section 14.1 First Participation Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance 7.3(a) Xxxxxxx Xxxxx Preamble GSIP Preamble GSPO Preamble HK Subsidiary Preamble HKIAC Section 11.18(b16.3 HKIAC Arbitration Rules Section 16.3 Infinity Preamble Investor Preamble Investor Acceptance Period Section 8.3(b) Clifford Chance Privileged Communications Investor Additional Quantity Section 11.18(b7.3(b) Clifford Chance Waiving Investor Offered Equity Securities Section 8.3(a) Investor Participation Notice Section 7.3(b) Investor Participation Period Section 7.3(b) Investor Second Notice Section 8.3(d) Investor Tag-along Acceptance Notice Section 8.3(e) Investor Tag-along Pro Rata Portion Section 8.3(f) Investor Transfer Notice Section 8.3(a) Investors Preamble Key Holders Preamble New Access Preamble New Access Qianjing Preamble New Access Qianlong Preamble New Securities Section 7.2 Non-Disposing Parties Section 11.18(b8.2(a) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Non-purchased Investor Offered Equity Securities Section 5.12(a8.3(d) HCM Shareholders’ Meeting Non-purchased Offered Equity Securities Section 8.2(b8.2(d) HoldCo Preamble Incentive Offered Equity Plan Securities Section 6.10(a8.2(a) Individual Financial Statements Over-Purchasing Investor Section 4.7(a)(ii8.2(d) Intended Tax Treatment Recitals Interim Period Over-Purchasing Party Section 6.1 JOBS Act 8.3(d) Partnership Election Section 5.6(a15.9 Participation Investor Section 7.3(b) K&S Participation Right Holder Section 11.18(a7.3(a) K&S Privileged Communications Participation Right Persons Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e7.3(c) Parties Preamble Permitted Transferee Section 8.1(b) PFIC Section 15.9 Principal Preamble Principal Holding Company Preamble Pro Rata Share Section 7.1 Proposing Investor Section 8.4(a) Right of Participation Section 7.1 Second Notice Section 8.2(d) Second Participation Notice Section 7.3(c) Second Participation Period Section 7.3(c) Selling Shareholders Section 8.4(a) Shareholder Consent Section 8.4(a) Stelca Preamble Tag-along Acceptance Notice Section 8.2(e) Tag-along Offer Period Section 8.2(e) Tag-along Pro Rata Portion Section 8.2(f) Third Party Preamble Personal Information Laws and Policies Purchaser Section 4.22(a8.2(a) Processors Transfer Notice Section 4.22(a8.2(a) Prospectus Violation Section 11.1 Proxy Statement Section 8.2(a)(i5.1(a) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7Zunyi Preamble

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Number Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii7.4 (ii) Agreement Preamble Ancillary Agreements Approved Sale Section 11.10 Authorization 11.1 Arbitration Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance 13.5 (i) Auditors Section 11.18(b8.1(i) Clifford Chance Privileged Communications Circular 37 Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals 12.17 Company Preamble Coatue Director Section 9.1 (iii) Corporate Opportunity Section 12.28(iii) Competitors Section 8.1 Confidential Information Section 12.13 (i) Direct US Investor Section 12.11 (iii) Disclosing Party Section 12.13 (iii) Dispute Section 13.5 (i) Dissenting Member Section 11.5 Domestic Company Benefit Plan Preamble Domestic Equity Transfer Section 4.13(a12.3 Effective Date Preamble ESIP Section 12.1 Exempt Registrations Section 3.4 First Participation Notice Section 7.4 (i) Founder/Founders Preamble GGV Preamble GGV Director Section 9.1(i) HES Preamble Hearst Preamble Xxxxxxxxx Preamble Xxxxxxxxx Director Section 9.1 (ii) HK Company Common Stock Preamble HKIAC Section 4.5(a13.5 (ii) Company Cure HKIAC Rules Section 13.5 (ii) IDG Preamble IDG Director Section 9.1(i) IDG Venture IV Preamble IDG Venture V Preamble Indirect US Investor Section 12.11 (iii) Investors/Investor Preamble Investor Director(s) Section 9.1(i) Key Ordinary Shareholder Preamble Majority Ordinary Director Section 9.1(i) Matrix Preamble Meeting Notice Section 9.3 Xx. Xxxx Preamble Xx. Xxxxx Preamble Xx. Xxx Preamble New Entity Section 8.3(i) New Securities Section 7.3 Observer Section 9.1(iii) Oversubscription Participant Section 7.4 (ii) Party/Parties Preamble PFIC Annual Information Statement Section 12.11(iii) PFIC Shareholder Section 12.11 (iii) Prior Agreement Recitals Preemptive Right Section 7.1 Preemptive Rights Holder Section 7.1 Pro Rata Share Section 7.2 Qingting Preamble Remaining Members Section 11.2 Restricted Business Section 12.9 Restricted Investment Section 8.1 SAFE Rules and Regulations Section 12.17 Second Participation Notice Section 7.4 (ii) Second Participation Period Section 10.1(e7.4 (ii) Company Expenses Overrun Security Holder Section 8.7(b12.17 Selling Investor Section 12.12(ii) Company Indemnified Parties Series A/A-1 Investment Amount Section 6.8(a12.12(ii) Company Real Property Series C Investment Amount Section 4.20(a12.12(ii) Company Registered Intellectual Property Series D Investment Amount Section 4.21(a12.12(ii) Confidentiality Agreement Series D+ Investment Amount Section 11.10 Constituent Companies 12.12(ii) Series E Investment Amount Section 2.2(a12.12(ii) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Series E Purchase Agreement Recitals Merger Recitals Merger Right Subsidiary Board Section 3.1(a9.1 (ii) Modification in Recommendation Shunwei Preamble Shunwei Director Section 8.2(b9.1(i) Multiemployer Plan Transfer Section 4.13(b12.14 Violation Section 5.1(i) Nasdaq Section 4.4 New CayCo WFOE Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties WFOE’s Subsidiary Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7Yun Qi Preamble

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Term: Section: 401(k) Plan Participants Section 6.3 2023 Financial Statements 6.04 Agreed Accounting Adjustment Section 6.3 Additional Deposit Amount 2.07 Agreement Date Section 7.6 Affiliate Agreements 5.15 agreements Section 4.12(a)(vii) 3.05 ATS Section 2.02 ATS Distribution Agreement Section 5.14 ATS Related Rights Section 5.14 Austin Facility Section 3.16 Bankrupt Obligor Section 2.08 Base Cash Purchase Price Section 2.02 Base Purchase Price Section 2.02 Centerpulse Preamble Ancillary Agreements Section 11.10 Authorization Change Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance 7.07 Class Action Settlement Section 11.18(b) Clifford Chance Privileged Communications 8.02 Class Action Settlement Agreement Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) 8.02 Closing Section 2.4(a) 2.03 Closing Accounts Receivable Section 2.08 Closing Date Section 2.4(a2.03 CMI Recitals Competitive Business Section 5.07 Complete Section 5.12 Confidentiality Agreement Section 5.02 contracts or Contracts Section 3.05 Cryolife Litigation Section 9.03 CVD Recitals CVNL Recitals discontinuation decision Section 5.13 Diversified Company Section 5.07 Xxxxxxx Litigation Section 9.03 Elections Section 7.07 equity interests Section 3.03 Excluded Liabilities Section 9.03 Exclusivity Period Section 5.14 Exercise Period Section 5.14 Existing Vancouver Facility Section 3.16 FDA Mitroflow Tissue Valve Approval Section 5.13 Final Closing Balance Sheet Section 2.07 Final Tax Amount Section 7.02 Foreign Agreements Section 2.04 Foreign Closing Section 2.04 Government Antitrust Authority Section 5.05 Granted Rights Section 5.14 Guaranty Section 11.16 Indemnifiable Claim Section 9.04 Indemnifiable Liabilities Section 9.03 Indemnified Party Section 9.04 Indemnifying Party Section 9.04 Independent Accounting Firm Section 2.07 Lehman Section 3.21 Losses Section 9.02 Material Contracts Section 3.15 Maximum Amount Section 9.03 MIT Recitals Mitroflow Parties Section 5.13 Net Receivables Section 2.08 New Confidentiality Agreement Section 5.05 New Vancouver Facility Section 3.16 Non-Competition Period Section 5.07 Note Section 2.02 Offer Notice Section 5.14 physical inventory Section 2.07 Potential Mitroflow Obligations Section 5.13 prime rate Section 2.07 Principal Real Property or Principal Real Properties Section 3.16 Prospective Transferees Section 5.14 Purchase Price Section 2.02 Purchaser Preamble Purchaser Indemnified Party Section 9.03 Purchaser's Notice Section 5.14 Purchaser Plan Section 6.04 Purchaser's Threshold Amount Section 9.02 Purchaser Transition Services Agreement Section 5.10 Purchaser's Accountants Section 2.07 Reference Balance Sheet Section 3.07 Right of First Refusal or Rights of First Refusal Section 5.14 Right of First Refusal Granted Rights Section 5.14 Section 338 Elections Section 7.07 Section 338 Forms Section 7.07 Section 338 Schedule Section 7.07 Seller Preamble Seller 401(k) Code Plan Section 6.04 Seller Indemnified Party Section 9.02 Seller Transition Services Agreement Section 5.10 Seller's Accountants Section 2.07 Seller's ATS Rights Section 2.02 Seller's Threshold Amount Section 9.03 Selling Entities Section 3.01 Shares Recitals Company SNIA Preamble Straddle Period Return Section 7.02 Subordinated Note Section 2.02 Subsidiary Shares Section 3.03 Target Companies Recitals Target Company Benefit Plan Plans Section 4.13(a) 3.17 Target Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement 3.14 Tax Items Section 11.10 Constituent Companies 7.02 Tax Indemnified Party Section 2.2(a) Contributions Recitals Converted Warrant 7.04 Tax Indemnifying Party Section 3.4 Corporate Records 7.04 Term Sheet Provisions Section 4.7(a) D&O Indemnified Parties 5.14 Transaction Agreements Section 6.8(a) Effective Time 3.01 Transfer Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.75.14 Valves Business Recitals

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms have the meanings defined for such terms in the Sections set forth below: Accrued Vacation Credit Section 6.3 2023 Financial Statements 7.7(b) Acquisition Proposal Section 6.3 7.5 Additional Deposit Amount Consideration Section 7.6 Affiliate Agreements Section 4.12(a)(vii) 3.5 Agreement Preamble Ancillary Agreements Allocation Schedule Section 11.10 Authorization Notice 3.3 Alternate Cash Payment Section 7.7 Cash Contribution 3.2(d) Assigned Contracts Section 2.3(a)(i) Assumed Capital Lease Obligations Section 2.3(a)(ii) Assumed Liabilities Section 2.3(a) Assumed Payables Section 2.3(a)(iii) Assumption Agreement Section 2.3(a) Business Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Business Employees Section 11.18(b7.7(b) Clifford Chance Privileged Communications Buyer Preamble Buyer Indemnitee Section 11.18(b11.2 Buyer Party Preamble Buyer Parent Preamble Buyer Required Consents and Authorizations Section 6.2(b) Clifford Chance Waiving Parties Charges Section 11.18(b) Clifford Chance WP Group 7.12 Claim Section 11.18(b) Closing Section 2.4(a11.4(a) Closing Date Deadline Section 2.4(a10.1(e) Code Recitals Company Preamble Closing Date Lease Payment Amount Section 2.3(c) Closing Date Working Capital Statement Section 3.4(a) Closing Statement Section 3.2(a) Collection Period Section 7.15 Company Benefit Plan Section 4.13(a5.14(a) Company Common Stock Data Section 4.5(a5.24(a) Company Cure Period Telecom Permits Section 10.1(e5.22(b) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Consulting Agreement Section 11.10 Constituent Companies 7.7(a) Customer Data Section 2.2(a5.24(a) Contributions Recitals Converted Warrant Customer List Section 3.4 Corporate Records 5.18 Deemed Acceptance Section 4.7(a11.4(a) D&O Indemnified Parties Designated Expenses Section 6.8(a3.5(c) Effective Time Disclosure Schedule Article V Dispute Notice Section 2.4(b11.4(a) ERISA Employment Agreements Section 4.13(a7.7(a) Employment Termination Date Section 3.5(g) Escrow Agreement Section 3.2(d) Exchange Agent Act Section 3.2(a3.5(h) Expenses Cap Excluded Assets Section 8.7(b2.2 Excluded Liabilities Section 2.3(b) Export Approvals Existing Lease Assignments Section 4.26(a8.8(b) Extended End Date Existing Leases Section 10.1(h5.6(b) Final Resolution Section 11.6 Financial Statements Section 4.7(a)(ii5.3(a) FTA Guaranteed Capital Leases Section 4.15(y2.3(c) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Holdback Amount Section 3.2(b) Listing Application Holdback Period Section 6.7 3.6 Indemnified Party Section 11.4(a) Indemnifying Party Section 11.4(a) Insurance Policy Section 5.8 Interim Balance Sheet Section 5.3(a) Issue Date Price Per Share Section 3.2(c) Large Customer Section 5.18 Leased Premises Section 5.6(b) Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a3.2(c) Modification in Recommendation Losses Section 8.2(b11.2 Material Consents and Authorizations Section 8.6 Minimum Claim Threshold Section 11.5(a) Multiemployer Plan Minimum Cumulative EBITDA Amount Section 4.13(b3.5(b) Nasdaq Minimum Cumulative Revenue Amount Section 4.4 New CayCo Preamble Offer 3.5(a) Parent SEC Documents Section 8.2(a)(i6.6 Parent Shares Section 3.2(c) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws Pre-Closing Activities Section 7.1(b) Pre-Sale Month End Date Section 3.5(h) Projections Section 3.5(c) Purchase Price Section 3.1 Purchase Price Reduction Amount Section 3.4(c) Purchased Assets Section 2.1 Representation and Policies Warranty Insurance Section 4.22(a7.13 Representation Claim Section 11.5(a) Processors Restricted Period Section 4.22(a7.14(b) Prospectus Restricted Persons Section 11.1 Proxy Statement 7.14 Rule Section 8.2(a)(i5.25 Sale Event Section 3.5(h) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation SEC Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Seller Governmental Authorizations Section 10.1(e5.9(a) Terminating HCM Breach Seller Indemnitee Section 10.1(g11.3 Seller Required Consents and Authorizations Section 5.2(c) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Special Representations Section 11.1 Trust Agreement Target Working Capital Section 5.8 Trustee 3.4(c) Tax Benefit Section 5.8 Warrant Assumption Agreement 11.5(d) Territory Section 3.4 Warrant Exchange 7.14 Third Party Claim Section 3.4 Written Objection 11.4(b) Threshold Section 7.711.5(a) True-Up Credit Section 7.16 Uncollected Receivables Section 7.15 USAC Section 2.2 WARN Act Section 2.3(b)(ix)

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Definition Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(viiAdjustment Number 2.2(b) Aggregate Number 2.2(b) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Asset Transfer Recitals Asset Transfer Documents Recitals Automobile Purchase Contract 4.10(a) Beneficiary 7.22 Beneficiary Exercise Price 7.23(a) Business Cooperation Agreement Recitals BVI Holdco Recitals Cash Contribution Consideration Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(aCFC 6.9 Claims 9.2(a) Code Recitals 6.8 Company Preamble Company Benefit Plan Section 4.13(aSecurity Holder 6.13(a) Company Common Stock Section 4.5(aConstitutional Documents 4.14 Conversion Shares 4.3 Cooperation Recitals Cooperation Documents Recitals Covered Persons 4.13 Damages 9.2(a) Company Cure Period Section 10.1(eDisclosing Party 10.10(c) Company Expenses Overrun Section 8.7(bDisclosure Schedule 4 Domco Preamble Employment Agreements 7.13 Employment Matters Agreement Recitals Exercise Price 7.23(a) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(hExisting Shareholders Preamble FCPA 6.13(b) Financial Statements Section 4.7(a)(ii4.18 First Closing 3.1(a) FTA Section 4.15(yFirst Closing Date 3.1(a) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(gFirst Closing Purchase Price 2.2(a) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Framework Agreement Recitals Merger Recitals Merger Right Section 3.1(aGroup Company or Business Contracts 4.14 Hammer Schedule A Hammer Director 7.9 HK Holdco Preamble HKIAC Rules 10.13(a) Modification in Recommendation Section 8.2(bIndemnification Agreements 7.18 Indemnified Party 9.2(a) Multiemployer Plan Section 4.13(bIndemnifying Party 9.2(a) Nasdaq Section 4.4 New CayCo Initial Exercise Price 7.23(a) Investor Option 2.2(b) Investors Preamble Offer Documents Section 8.2(a)(iJD Schedule A Joint Venture Affiliate 4.2(d) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Key Employees 4.23 Leased Real Property Leases Section 4.20(b)(iii4.8 Long-Stop Date 10.15(a)(ii) Registrar Section 2.4(bMaterial Contracts 4.10(a) Registration Rights New Employers Recitals New Investor 2.2(c) Next Round Financing 2.3 Nominee Shareholder(s) 6.13(e) Non-Disclosing Parties 10.10(c) Non-Transferred Asset 6.1(c) Note Purchase Agreement Recitals Registration Statement Ordinary Shares 4.2(a)(i)(A) Permits 4.7 PFIC 6.8 PRC Companies Preamble PRC GAAP 4.18 Preferred A Issue Price 2.2(a) Privacy Laws 4.31 Proceeds 6.5 Remaining Number 2.2(c) Restated Articles 2.1 Second Closing 3.1 Second Closing Date 3.1(b) Securities Section 8.2(a)(iAct 4.12 Series A-1 Directors 7.9 Series A-1 Shares Recitals Series A-2 Shares Recitals Series Pre-A Shares Recitals Share Charge 7.11 Success Fee 4.27 Tencent Schedule A Tencent Director 7.9 Trust 7.22 Trust Arrangement 7.23 Trust Holdco Preamble Trust Holdco Subscription Agreement 7.23 Trust Ordinary Shares 7.23 Warrantor 4 Warrantors 4 WFOE Preamble Xintai 6.13(h) Reorganization Yixin Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7Yixin Note Recitals

Other Defined Terms. Each of the terms set forth below has the meaning set forth in the provision set forth opposite such term in the following table: Term Location 2022 Provision Aggregate Basket Section 11.5(a) Agreement Preamble Asset Acquisition Statement Section 1.5 Assignment Section 2.3(a) Assignment Documents Section 2.3(a) Books and Records Section 7.7 Bridge Note Amount Section 1.3(b) Cash Purchase Price Section 1.2 Closing Section 2.1 Closing Date Section 2.1 Closing Purchase Price Section 1.2 Common Stock Purchase Price Section 1.2 Company Preamble Company Audited Financial Statements Section 6.3 2023 5.6 Company Contracts Section 5.13 Company Employees Section 7.9(e) Company Financial Statements Section 6.3 Additional Deposit 5.6 Company Latest Balance Sheet Section 5.6 Company Leasehold Property Section 5.11(b) Company Material Leases Section 5.11(b) Company Owned Real Estate Section 5.11(a) Company Senior Officers Section 5.8(e) Company Unaudited Financial Statements Section 5.6 Construction Cost Estimate Schedule Section 7.3(k) Covered Losses Section 11.4(a) Cut-Off Date Section 7.16 Term Provision Delay Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii11.2(b) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) Disclosure Schedule Article IV D&O Indemnified Parties Section 6.8(a7.10(a) Effective Time DOJ Section 2.4(b4.1(d) ERISA Escrow Agreement Section 4.13(a2.2 FIRPTA Certificate Section 7.16 FTC Section 4.1(d) Exchange Agent Losses Section 3.2(a11.2(a) Expenses Cap NYSE Section 8.7(b2.2 OpCo Holdings Section 7.2 Payoff Evidence Section 2.3(b) Export Approvals Per Occurrence Basket Section 4.26(a11.5(a) Extended End Date Project Start-Up and Testing Activities Section 10.1(h11.2(b) Financial Statements Purchaser Preamble Purchaser Disclosure Schedule Article VI Purchase Price Section 4.7(a)(ii1.2 Purchaser Covered Losses Section 11.5(a) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Purchaser Indemnified Parties Section 6.8(a11.2(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Purchaser Plan Section 6.10(a7.9(e) Individual Financial Statements Purchaser Reports Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b6.6(a) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i2.3(g) Reorganization Recitals Reorganization Documentation Revised Statements Section 6.6 1.5 Sarbanes Oxley Act Section 6.6(d) SEC Section 6.6(a) Securityholder Covered Losses Section 11.5(a) Securityholder Indemnified Parties Section 11.3(a) Securityholders’ Representatives Section 3.1 Seller Preamble Sponsor Parties Recitals Surviving Subordinated Note Amount Section 1.3(a) Tax Purchase Price Section 1.5 Terminated Affiliated Contracts Section 5.22 Third-Party Claim Section 11.4 Voting Company Recitals Terminating Company Breach Debt Section 10.1(e5.5 Voting Purchaser Debt Section 6.5 Voting Subsidiary Debt Section 5.9(c) Terminating HCM Breach WARN Act Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.77.9(b)

Other Defined Terms. The following terms have the meanings set forth in the Sections set forth below: Defined Term Location 2022 Audited of Definition Additional Proposal Section 7.01(d) Amendment Proposal Section 7.01(d) Antitrust Remedial Actions Section 7.05(c) Certificate of Merger Section 2.04 Closing Section 2.03 Florida Affiliate Agreement Section 4.23 Confidentiality Agreement Section 7.15(a) Copyrights Section 1.01 Effective Time Section 2.04 ERISA Section 4.17(a) ERISA Affiliate Section 4.17(d) Florida Preamble Florida Board Recitals Florida Benefit Plan Section 4.17(a) Florida Data Room Section 1.03(a) Florida Distribution Tax Counsel Section 7.06(b) Florida Distribution Tax Opinions Section 7.06(b) Florida Financial Statements Section 6.3 2023 4.07 Florida IP Contracts Section 4.20(a)(iv) Florida Marks Section 4.15(c) Florida Material Contracts Section 4.20(a) Florida Merger Tax Counsel Section 7.06(b) Florida Merger Tax Opinion Section 7.06(b) Florida Preliminary Unaudited Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company 4.07 Florida Real Property Leases Section 4.20(a4.20(a)(v) Company Registered Intellectual Property Florida Tax Opinions Section 4.21(a7.06(b) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Florida Unaudited Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) 4.07 Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act 6.01 IPO Section 5.6(a7.09 IPO Prospectus Section 7.09 LLC Sub Recitals LLC Sub Merger Recitals LLC Sub Merger Agreement Section 2.06 Lockup Agreements Recitals Marks Section 1.01 Merger Section 2.02 Merger Consideration Calculation Section 3.01(a) K&S Merger Sub Preamble Multiemployer Plan Section 11.18(a4.17(d) K&S Privileged Communications NYSE Proposal Section 11.18(a7.01(d) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) NYSE Listing Application Section 6.7 Lock-Up Agreement 7.10(b) Offer Recitals Merger Recitals Merger Right Patents Section 3.1(a) Modification in Recommendation 1.01 PIPE Investment Amount Section 8.2(b) Multiemployer Plan 5.25 Proposals Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b7.01(d) Registration Rights Agreement Recitals Registration Statement Securities Released Claims Section 8.2(a)(i7.09 Released Parties Section 7.09 Required Florida Stockholder Approval Recitals Separation Agreement Recitals Shares Section 3.01(b) Reorganization SPAC Preamble SPAC Newco A&R Bylaws Recitals Reorganization Documentation SPAC Newco A&R Charter Recitals SPAC Affiliate Agreement Section 6.6 Seller Preamble 5.24 SPAC Benefit Plans Section 5.13 SPAC Board Recitals SPAC Board Recommendation Section 7.01(e) SPAC Change in Recommendation Section 7.01(e) SPAC Material Contracts Section 5.15(a) SPAC Newco Omnibus Incentive Plan Recitals SPAC Newco Omnibus Incentive Plan Proposal Section 7.01(d) SPAC Stockholder Approval Section 5.02(b) Special Meeting Section 5.02(b) Split-Off Agreement Recitals Sponsor Parties Agreement Recitals Stockholders Agreement Recitals Subscribers Recitals Subscription Agreements Recitals Surviving Company Recitals Corporation Section 2.02 Termination Date Section 9.01(a) Terminating Company SPAC Breach Section 10.1(e9.01(d) Terminating HCM Florida Breach Section 10.1(g9.01(e) Title IV Plan Texas Certificate of Merger Section 4.13(b) Top Vendors 2.01 Third Party Target Section 4.28(a) 5.20 Trade Secrets Section 1.01 Transaction Litigation Proposal Section 8.6 Transaction Proposals Section 8.2(b7.01(d) Trust Account Section 11.1 5.18 Trust Agreement Section 5.8 5.18 Trustee Section 5.8 Warrant Assumption Agreement 5.18 TX Merger Effective Time Section 3.4 Warrant Exchange Section 3.4 2.01 Written Objection Section 7.7Consent Recitals

Other Defined Terms. Term ​ ​ Location 2022 Audited Financial Statements ​ ​ Section 6.3 2023 Financial Statements ​ ​ Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements ​ ​ Section 4.12(a)(vii) Agreement ​ ​ Preamble Ancillary Agreements ​ ​ Section 11.10 Authorization Notice ​ ​ Section 7.7 Cash Contribution Subscription ​ ​ Recitals Cayman Companies Act ​ ​ Recitals Xxxxxxxx Clifford Chance ​ ​ Section 11.18(b) Clifford Chance Privileged Communications ​ ​ Section 11.18(b) Clifford Chance Waiving Parties ​ ​ Section 11.18(b) Clifford Chance WP Group ​ ​ Section 11.18(b) Closing ​ ​ Section 2.4(a) Closing Date ​ ​ Section 2.4(a) Code ​ ​ Recitals Company ​ ​ Preamble Company Benefit Plan ​ ​ Section 4.13(a) Company Common Stock ​ ​ Section 4.5(a) Company Cure Period ​ ​ Section 10.1(e) Company Expenses Overrun ​ ​ Section 8.7(b) Company Indemnified Parties ​ ​ Section 6.8(a) Company Real Property ​ ​ Section 4.20(a) Company Registered Intellectual Property ​ ​ Section 4.21(a) Confidentiality Agreement ​ ​ Section 11.10 12 Term ​ ​ Location Constituent Companies ​ ​ Section 2.2(a) Contributions Recitals Converted Warrant ​ ​ Section 3.4 Corporate Records ​ ​ Section 4.7(a4.7(e) D&O Indemnified Parties ​ ​ Section 6.8(a) Dutch Murano ​ ​ Preamble Effective Time ​ ​ Section 2.4(b) ERISA ​ ​ Section 4.13(a) Exchange Agent ​ ​ Section 3.2(a) Expenses Cap ​ ​ Section 8.7(b) Export Approvals ​ ​ Section 4.26(a) Extended End Date ​ ​ Section 10.1(h) Financial Statements ​ ​ Section 4.7(a)(ii) FTA ​ ​ Section 4.15(y4.15(x) Government Contract ​ ​ Section 4.29 HCM ​ ​ Preamble HCM Cure Period ​ ​ Section 10.1(g) HCM Expenses Cap ​ ​ Section 8.7(b) HCM Expenses Overrun ​ ​ Section 8.7(b) HCM Financial Statements ​ ​ Section 5.6(d) HCM Indemnified Parties ​ ​ Section 6.8(a) HCM SEC Filings ​ ​ Section 5.5 HCM Securities ​ ​ Section 5.12(a) HCM Shareholders’ Meeting ​ ​ Section 8.2(b) HoldCo Preamble Incentive Equity Plan ​ ​ Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment ​ ​ Recitals Interim Period ​ ​ Section 6.1 JOBS Act ​ ​ Section 5.6(a) K&S ​ ​ Section 11.18(a) K&S Privileged Communications ​ ​ Section 11.18(a) K&S Waiving Parties ​ ​ Section 11.18(a) K&S WP Group ​ ​ Section 11.18(a) Legal Proceedings ​ ​ Section 4.10 Letter of Transmittal ​ ​ Section 3.2(b) Listing Application ​ ​ Section 6.7 Lock-Up Agreement ​ ​ Recitals Merger ​ ​ Recitals Merger Right Section 3.1(a) Modification in Recommendation ​ ​ Section 8.2(b) Multiemployer Plan Section 4.13(b) Murano Holding ​ ​ Preamble Murano Parties ​ ​ Preamble Nasdaq ​ ​ Section 4.4 New CayCo ​ ​ Preamble Offer Documents ​ ​ Section 8.2(a)(i) Other Indemnitors ​ ​ Section 6.8(e) Parties ​ ​ Preamble Party ​ ​ Preamble Personal Information Laws and Policies ​ ​ Section 4.22(a) Processors ​ ​ Section 4.22(a) Prospectus ​ ​ Section 11.1 Proxy Statement ​ ​ Section 8.2(a)(i) Proxy Statement/Registration Statement ​ ​ Section 8.2(a)(i) Term ​ ​ Location PubCo ​ ​ Preamble PubCo Reorganization ​ ​ Recitals Q2 Financial Statements ​ ​ Section 4.7(a)(ii) Q3 Financial Statements ​ ​ Section 6.3 Real Property Leases ​ ​ Section 4.20(b)(iii) Registrar ​ ​ Section 2.4(b) Registration Rights Agreement ​ ​ Recitals Registration Statement Securities ​ ​ Section 8.2(a)(i) Reorganization ​ ​ Recitals Reorganization Documentation ​ ​ Section 6.6 6.6(a) Seller ​ ​ Preamble Sponsor Parties ​ ​ Recitals Subscriptions ​ ​ Recitals Surviving Company ​ ​ Recitals Terminating Company Breach ​ ​ Section 10.1(e) Terminating HCM Breach ​ ​ Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors ​ ​ Section 4.28(a) Transaction Litigation ​ ​ Section 8.6 Transaction Proposals ​ ​ Section 8.2(b) Trust Account ​ ​ Section 11.1 Trust Agreement ​ ​ Section 5.8 Trustee ​ ​ Section 5.8 Warrant Assumption Agreement ​ ​ Section 3.4 Warrant Exchange ​ ​ Section 3.4 Written Objection ​ ​ Section 7.7

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Number Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii7.4(b) Agreement Preamble Ancillary Agreements Appointing Shareholder(s) Section 11.10 Authorization 9.2(b) Approving Holders Section 12.10 Arbitration Notice Section 7.7 Cash Contribution 13.5(a) Business Recitals Cayman Companies Act Recitals Xxxxxxxx Chance CEO Section 11.18(b11.1(a) Clifford Chance Privileged Communications CFC Section 11.18(b12.7(d) Clifford Chance Waiving Parties CFO Section 11.18(b11.2 Chairman Section 9.1(a) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Confidential Information Section 12.14(a) Didi Exercise Period Section 12.12(a) Didi Minimum Percentage Section 12.12(b) Didi Observer Section 9.4 Didi Option Section 12.12(a) Direct US Investor Section 12.7(c) Dispute Section 13.5(a) Domestic Company Benefit Preamble Effective Date Preamble ESOP Section 12.9(a) ESOP Plan Section 4.13(a12.9(d) Company Common Stock 8 Shareholders Agreement ESOP Shares Section 4.5(a12.9(a) Company Cure Exempt Registrations Section 3.4 Exercise Price Section 12.9(b) First Participation Notice Section 7.4(a) First Participation Period Section 10.1(e7.4(a) HKIAC Section 13.5(b) HKIAC Rules Section 13.5(b) HK Company Expenses Overrun Preamble Incentive Employees Section 8.7(b12.9(a) Company Indemnified Parties Indirect US Investor Section 6.8(a12.7(c) Company Real Property Investor(s) Preamble Investor Director(s) Section 4.20(a9.1(a) Company Registered Intellectual Property Losses Section 4.21(a12.5(a) Confidentiality New Securities Section 7.3 Observer(s) Section 9.4 Ordinary Directors Section 9.1(a) Oversubscription Participants Section 7.4(b) Partnership(s) Preamble Participation Notice Section 7.4 (b) Party(ies) Preamble PFIC Section 12.7(c) PFIC Shareholder Section 12.7(c) Preemptive Right Section 7.1 Preemptive Rights Holder Section 7.1 Principal(s) Preamble Principal Holding Company(ies) Preamble Pro Rata Share Section 7.2 Purchase Agreement Recitals PV Observer Section 11.10 Constituent Companies 9.4 Representatives Section 2.2(a12.14(b) Contributions Recitals Converted Warrant Restricted Business Section 3.4 Corporate Records Section 4.7(a12.3(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Services Period Section 10.1(g12.3(b) HCM Expenses Cap Second Participation Notice Section 8.7(b7.4(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Second Participation Period Section 6.1 JOBS Act 7.4(b) Security Holder Section 5.6(a12.16 Subsidiary Board Section 9.1(b) K&S Taikang Director Section 11.18(a9.1(a) K&S Privileged Communications TK Director Veto Matters Section 11.18(a10.2(c) K&S Waiving Parties Tencent Director Section 11.18(a9.1(a) K&S Tencent Director Veto Matters Section 10.2(d) Trade Sale Section 12.10 Vacancy Period Section 9.2(b) Violation Section 5.1(a) WFOE Preamble WP Group Director Section 11.18(a9.1(a) Legal Proceedings WP Director Veto Matters Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.710.2(b)

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Number Section 6.3 2023 Financial Statements 4.4(b) Additional Offered Shares Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii5.2(b) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Arbitration Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance 16.2(a) Available Fund Section 11.18(b9.2(a) Clifford Chance Privileged Communications CFC Section 11.18(b) Clifford Chance Waiving Parties 14.3 Code Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals 14.3 Company Preamble Company Benefit Plan Competitor Section 4.13(a5.6(a) Company Common Stock Confidential Information Section 4.5(a17.1(a) Company Cure Period Conversion Notice Section 10.1(e11.1(c) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Connect Australia Preamble Connect Beijing Preamble Connect HK Preamble Connect Shanghai Preamble Connect Suzhou Preamble Connect US Preamble Demand Notice Section 3.2(a) Expenses Cap Dispute Section 8.7(b16.2 Drag-Along Sale Section 6.1 Drag Holder Section 6.1 Drag Notice Section 6.1 ESOP Holdco Preamble Exercising Shareholder Section 5.2(b) Export Approvals Financing Terms Section 4.26(a17.1(a) Extended End First Participation Notice Section 4.4(a) First Participation Period Section 4.4(a) Founder Directors Section 8.1 Founder/Founders Preamble HKIAC Section 16.2(b) HKIAC Rules Section 16.2(b) Liquidation Payment Notice Section 10.1(f) New Securities Section 4.3 Offered Shares Section 5.2(a) Offeror Section 6.1 Option Period Section 5.2(b) Other Shareholders Section 6.1 Over-Exercising Shareholders Section 5.2(b) Party/Parties Preamble PFIC Section 14.4 Preemptive Right Section 7.1 Preemptive Rights Holder Section 7.1 Prior Agreement Recital Pro Rata Share Section 4.2 QEF Election Section 14.4 Redemption Event Section 9.1 Redemption Payment Notice Section 9.2(b) Restricted Holder Section 5.1(a) Rights Holder Section 4.1 Right Participants Section 4.4(b) ROFR Shareholder Section 5.2(b) Second Participation Notice Section 4.4(b) Second Participation Period Section 4.4(b) Second Transfer Notice Section 5.2(b) Series A Director Section 8.1 Series A Preference Amount Section 10.1(c) Series A Redemption Price Section 9.1(c) Series A Redemption Request Section 9.1(c) Series B Director Section 8.1 Series B Preference Amount Section 10.1(b) Series B Redemption Price Section 9.1(b) Series B Redemption Request Section 9.1(b) Series C Director Section 8.1 Series C Preference Amount Section 10.1(a) Series C Preferred Share Purchase Agreement Recitals Series C Redemption Price Section 9.1(a) Series C Redemption Request Section 9.1(a) Series Pre-A Preference Amount Section 10.1(d) Subsidiary Board Section 8.1 Target QIPO Date Section 10.1(h9.1 Transfer Section 5.1(a) Financial Statements Transfer Notice Section 4.7(a)(ii5.2(a) FTA Transferor Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.75.2(a)

Other Defined Terms. Term Location 2022 Audited The following capitalized terms shall have the meanings given to them in the Sections set forth below: Accountants Section 2.3(c) 14 Agreement Preamble 2 Answer Section 11.10(b) 56 Avure Sweden Shares Recitals 2 Avure Sweden Recitals 2 Avure USA Recitals 2 Balance Sheet Section 3.8(a) 19 Business Employees Section 3.17 26 Business Entities Recitals 2 Business Marks Section 3.16(a) 24 Business Patents Section 3.16(a) 24 Business Registered Copyrights Section 3.16(a) 24 Business Registered IP Section 3.16(a) 24 Cash Payment Section 2.2 13 Claimant Section 11.10(b) 56 Closing Section 2.5 15 Closing Adjustment Section 2.3(a) 13 Closing Cash Payment Section 2.3(a) 13 Closing Date Section 2.5 15 Closing Date Statement Section 2.3(b) Continuing Business Employees Section 9.5(a) 47 Copyrights Section 1.1 6 Demand Section 11.10(b) 56 Disputes Section 11.10 55 Estimated Net Working Capital Section 2.3(a) 13 FAS Shares Recitals 2 Final Cash Payment Section 2.3(d) 14 Financial Statements Section 6.3 2023 Financial Statements 3.8(a) 19 Flow Autoclave Recitals 2 Flow Business Conveyance Section 6.3 Additional Deposit Amount 5.13(a) 39 Flow Sweden Shares Recitals 2 Flow Sweden Recitals 2 Flow Switzerland Recitals 2 FMPB Business Section 1.1 3 Handelsbanken Guarantee Section 7.10 45 Inbound License Agreements Section 3.16(d) 25 Indemnified Party Section 9.3(c) 46 Indemnifying Party Section 9.3(c) 46 Industrial Process Business Section 1.1 3 License Agreement Section 7.6 Affiliate 43 Marks Section 1.1 6 Material Contracts Section 3.14 23 NewCo USA Shares Recitals 2 NewCo USA Recitals 2 Notes Section 2.2(c) Outbound License Agreements Section 4.12(a)(vii3.16(d) Agreement 25 Patents Section 1.1 6 Pre-Closing Transactions Section 5.13 39 Purchase Price Section 2.2 13 Purchaser Employer Section 9.5(a) 47 Purchaser Preamble Ancillary Agreements 2 Reply Section 11.10 Authorization Notice 11.10(b) 56 Respondent Section 7.7 Cash Contribution 11.10(b) 56 Seller Disclosure Schedule Section 3 15 Seller Preamble 2 Shares Recitals Cayman Companies Act Recitals Xxxxxxxx Chance 2 Straddle Periods Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality 1.1 9 Supply Agreement Section 11.10 Constituent Companies 6.9 41 Swiss Note Section 2.2(a5.13(c) Contributions Recitals Converted Warrant 39 Tax Indemnity Obligations Section 3.4 Corporate Records 5.12 39 Third Party Transaction Section 4.7(a5.3 35 Top 20 Section 3.15 24 Trade Secrets Section 1.1 7 Transferred Employees Section 9.5(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust 47 Transition Services Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.76.8 41

Other Defined Terms. The following terms shall have the meanings defined for such terms in the Sections set forth below: Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Section 6.3 10% ESOP Quota 19.14 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(viiNumber 7.4(b) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Alternative Plan 19.11(b) Arbitration Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b20.6(a) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Business Recitals Company Preamble Confidential Information 19.10(a) Co-Sale Notice 10.1 Xxxx Xxxx Preamble Dispute 20.6(a) Domestic Companies Preamble Drag Holders 15.1 Drag-Along Notice 15.1 Drag-Along Sale 15.1 Dragged Holders 15.1 Effective Date Preamble Exempt Registrations 3.4 Exercising Shareholder 9.2(c) First Participation Notice 7.4(a) First Participation Period 7.4(a) HK Company Benefit Plan Preamble HKIAC 20.6(b) HKIAC Rules 20.6(b) Investor’s Partners 19.13 Jifen Preamble New ESOP 18.1(f) New ESOP Anti-dilution Right 19.14 New Securities 7.3 Observer 17.1 Term Section 4.13(aOffered Shares 9.1 Offeror 15.1 Option Period 9.2(a) Company Common Stock Section 4.5(aOrdinary Director 17.1 Ordinary Shareholder Preamble Oversubscription Participants 7.4(b) Company Cure Participation Notice 7.4(b) Participation Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e7.4(b) Parties Preamble Party Preamble Personal Information Laws and Policies Permitted Transferee 12.1 Permitted Transferees 12.1 Preemptive Pro Rata Share 7.2 Preemptive Right 7.1 Principal Preamble Principal Holding Companies Preamble Principal Holding Company Preamble Principals Preamble Prohibited Transfer 13.1 Put Consideration 19.15(a) Put Notice 19.15(b) Put Right 19.15(a) Qukandian Preamble Re-allotment Period 9.2(c) Restricted Business 19.8 ROFR Pro Rata Share 9.2(b) Second Notice 9.2(c) Second Participation Notice 7.4(b) Second Participation Period 7.4(b) Selling Shareholder 10.1 Series A Director 17.1 Series A Investor Preamble Series A Investors Preamble Series A Share Purchase Agreement Recitals Series A Shareholders Agreement Recitals Series A1 Investor Preamble Series A1 Share Purchase Agreement Recitals Series A1 Shareholders Agreement Recitals Series B1 Director 17.1 Series B1 Investor Preamble Series B1 Share Purchase Agreement Recitals Series B2 Investors Preamble Series B2 Share Purchase Agreement Recitals Series B3 Investors Preamble Series B3 Share Purchase Agreement Recitals Term Section 4.22(aSeries B3 Shareholders Agreement Recitals Series C Director 17.1 Shelf Period 2.2(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Shelf Registration Statement Section 8.2(a)(i2.2 Shelf Takedown Request 2.2(b) PubCo Subpart F Income 19.13 Tokens 19.16 Transfer 8.1 Transfer Notice 9.1 Transferor 9.1 Tuile Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iiiVIE Event 19.11(b) Registrar Section 2.4(bViolation 5.1(a) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller WFOE Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7Xike Preamble Zhangduan Preamble

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings set forth in the section appearing opposite such term: AGREEMENT Recitals BANKRUPTCY CODE Section 6.3 2023 Financial Statements 3.1 COMPLETION OF SCREENING Section 6.3 Additional Deposit Amount 4.2 CONVERTIBLE NOTE Section 7.6 Affiliate Agreements 4.1 DESIGNATED SCREENING COMPOUND(S) Section 4.12(a)(vii2.8 DESIGNATED SHARED COMPOUND(S) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Notice 4A.2 DEVELOPMENT BUDGET Section 7.7 Cash Contribution 4A.7 DEVELOPMENT PLAN Section 4A.7 DISCONTINUED COMPOUND(S) Section 4A.3 DISCRETE COMPOUND(S) ATTACHMENT A DISPUTE NOTICE Section 9.1 EFFECTIVE DATE Recitals Cayman Companies Act EXCLUDED TARGET Section 2.2 EXPANDED COLLABORATION Section 2.1 FINAL TARGET REPORT ATTACHMENT A GENERIC RIGHTS Section 3.2 INDEMNIFIED PARTY(IES) Section 7.2 INDEMNIFYING PARTY Section 7.2 INDEPENDENT COMPOUND(S) Section 0X.00 XXXXXXXXXXX PARTY Section 0X.00 XXXXXXXXXXX PRODUCT Section 4A.15 IPO Section 4.1 LICENSED TECHNOLOGY Section 3.1 LOSSES Section 7.2 MARKETING BUDGET Section 4A.23 * = CONFIDENTIAL TREATMENT REQUESTED: MATERIAL HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. MARKETING PLAN Section 4A.23 NEOGENESIS Recitals Xxxxxxxx Chance NON-PROPOSED COMPOUND(S) Section 11.18(b4A.4 NON-PROPOSED COMPOUND INTERESTED PARTY Section 4A.4 OVERAGE THRESHOLD Section 4A.8 PRELIMINARY COMPOUND(S) Clifford Chance Privileged Communications ATTACHMENT A PRIMARY ACTIVE COMPOUND(S) ATTACHMENT A PROOF OF CONCEPT STAGE Section 11.18(b2.1 RE-ENGAGEMENT AMOUNT Section 4A.16 RE-ENGAGEMENT EXPIRATION DATE Section 4A.16 RE-ENGAGEMENT NOTICE Section 4A.16 SELECTED COMPOUND(S) Clifford Chance Waiving Parties ATTACHMENT A SELECTED SCREENING COMPOUND(S) ATTACHMENT A SELECTED SHARED COMPOUND(S) ATTACHMENT A SHARE OF LOSS Section 11.18(b) Clifford Chance WP Group 4A.17 SHARE OF PROFIT Section 11.18(b) Closing 4A.17 STEERING COMMITTEE Section 2.4(a) Closing Date 2.7 TERMINATED COUNTRIES Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.74A.23 TULARIK Recitals

Other Defined Terms. Term Location 2022 Audited Financial Statements Each of the following terms is defined in the Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii) set forth opposite such term: Agreement Preamble Ancillary Agreements Arbitrator Section 11.10 Authorization Notice 3.6(d) Canceled Shares Section 7.7 2.5(c) Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Consideration Section 11.18(b3.1 Certificate of Merger Section 2.1 Certificates Section 2.6(a) Clifford Chance Privileged Communications Claim Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a5.4(b) Closing Date Section 2.4(a8.1 Closing Date Holder Payment Statement Section 3.2(b) Code Recitals Company Preamble Company Benefit Plan Board Recommendation Section 4.2(b) Company Contracts Section 4.13(a) Company Common Stock Stockholder Approval Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a4.2(b) Confidentiality Agreement Section 11.10 Constituent Companies 6.2(b) Converted Stock Unit B-1 Share Cash Consideration Section 2.2(a3.3(b) Contributions Recitals Converted Warrant Stock Unit B-1 Shares Section 3.4 Corporate Records Section 4.7(a2.5(a) D&O Indemnified Parties Tail Premium Section 6.8(a6.7(c) Debt Section 5.4(b) Direct Claim Section 10.2(b) Dissenting Shares Section 2.5(d) Dissenting Stockholder Section 2.5(d) DMS Buyer Recitals DMS Purchase Agreement Recitals DMS Seller Section 6.14(a) DMS Transaction Section 6.14(a) Effective Time Section 2.4(b2.1 End Date Section 9.1(b) ERISA Engagement Section 4.13(a11.16(b) Exchange Agent Estimated Closing Cash Section 3.2(a) Estimated Closing Date Net Working Capital Section 3.2(a) Estimated Closing Statement Section 3.2(a) Estimated Transaction Expenses Cap Section 8.7(b3.2(a) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Evaluation Period Section 10.1(g3.6(b) HCM Expenses Cap FDA Section 8.7(b4.21(a) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b2.6(a) Listing Application Lithotech Earnout Escrow Amount Section 6.7 Lock-Up Agreement Recitals 3.1 Lithotech Earnout Escrow Fund Section 3.4 Merger Recitals Merger Right Sub Preamble Notice of Disagreement Section 3.1(a3.6(b) Modification in Recommendation Owned Real Property Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) 4.6 Parties Preamble Party Preamble Personal Information Laws and Policies Payoff Letters Section 4.22(a7.2(e) Processors Pre-Closing Period Tax Returns Section 4.22(a6.9(a) Prospectus Present Fair Salable Value Section 11.1 Proxy 5.4(b) Prior Company Counsel Section 11.16(a) Privilege Period Section 6.9(b) Proposed Closing Statement Section 8.2(a)(i3.6(a) Proxy Statement/Registration Statement Purchaser Preamble Purchaser Indemnitee Section 8.2(a)(i10.1 Representatives Section 6.2(a) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Securities Act Section 6.3 Real Property Leases 5.6 Solvency Section 4.20(b)(iii5.4(b) Registrar Solvent Section 2.4(b5.4(b) Registration Rights Agreement Recitals Registration Statement Securities Stockholder Approval Certificate Section 8.2(a)(i6.7 Stockholder Cash Consideration Section 3.3(a) Reorganization Recitals Reorganization Documentation Stockholder Representative Section 11.15(a) Stockholder Representative Reserve Section 3.1 Stockholder Vote Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Corporation Section 10.1(e2.2 Tax Proceeding Section 6.9(d) Terminating HCM Breach Third Party Claim Section 10.1(g10.2(a) Title IV Plan Total Incentive Cash Consideration Section 4.13(b3.3(b) Top Vendors Transfer Taxes Section 4.28(a6.9(h) Transaction Litigation Transferring Plans Section 8.6 Transaction Proposals Section 8.2(b6.9(h) Trust Account Section 11.1 Trust Transition Services Agreement Section 5.8 Trustee 6.5(b) VMDD Section 5.8 Warrant Assumption Agreement 6.14(b) VMI Section 3.4 Warrant Exchange 6.14(a) Working Capital Escrow Amount Section 3.4 Written Objection 3.1 Working Capital Escrow Fund Section 7.73.4

Other Defined Terms. Term Location 2022 Audited Each of the following terms is defined in the Section set forth opposite such term: Accounting Firm Section 2.4(b)(ii) Action Section 4.13 active fraud Section 8.14(c) Acquired Company Securities Recital Acquired Management Holdco Securities Recital Acquired Securities Recital Acquired ZMC Blocker Securities Recital Additional Management Holdco Financial Statements Section 6.3 2023 Financial Statements 6.9(b) Adjustment Escrow Account Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii2.3(b)(vi) Agreement Preamble Ancillary Agreements Documents Section 11.10 Authorization Notice 3.2 ASPE Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance 6.9(a) Audited Balance Sheet Section 11.18(b4.5(a) Clifford Chance Privileged Communications Blocker Financial Statements Section 11.18(b5.9(a) Clifford Chance Waiving Buyer Preamble Buyer Indemnified Parties Section 11.18(b9.2 Buyer Plans Section 8.11(a) Clifford Chance WP Group Buyer Released Parties Section 11.18(b8.13(b) Buyer Releasors Section 8.13(a) Calculations Exhibit G claim Section 7.5 Closing Section 2.4(a) 2.2 Closing Date Section 2.4(a2.2 Closing Statement Section 2.4(b)(i) Code Recitals Closing Statement Due Date Section 2.4(b)(i) Xxxxxxxx Holdco Preamble Xxxxxxxx Holdco Securities Recital Xxxxxxxx Sellers Preamble Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Latest Balance Sheet Section 4.5(a) Company Cure Period Securities Recital Company Software Section 10.1(e4.17(j) Continuing Employee Section 8.11(a) Credit Facility Pay-off Letter Section 10.2(g) CSIR Section 8.9(b) D&O Tail Policy Section 8.10(b) debt Section 7.5 Direct Claim Section 9.3(c) Escrow Agent Section 2.3(b)(vi) Escrow Agreement Section 2.3(b)(vi) Estimated Closing Statement Section 2.4(a) Estimated Purchase Price Section 2.4(a) Final Purchase Price Section 2.4(c)(i) Financial Statements Section 4.5(a) FLSA Section 4.18(i) Foreign Compeition Laws Section 3.3 Goodmans Section 12.16 Group Company Expenses Overrun IP Section 8.7(b4.17(a) Company Indemnified Parties IRS Section 6.8(a4.15(a) Company Xxxxxx Holdco Preamble Xxxxxx Holdco Securities Recital Xxxxxx Sellers Preamble Latest Balance Sheet Date Section 4.5(a) Latest Balance Sheets Section 4.5(a) Latest ZMC Balance Sheet Section 5.9(a) Leased Real Property Section 4.20(a4.20(b) Company Management Holdco Financial Statements Section 6.9(a) Management Holdco Securities Recital Management Holdcos Preamble Management Sellers Preamble Material Contracts Section 4.11(a) Material Customers Section 4.22(a) Material Vendor Section 4.11(a)(vi) Niagara Sellers Preamble Objection Section 2.4(b)(ii) Objection Notice Section 2.4(b)(ii) Offsetting Amounts Section 9.4 Xxxxxxx Holdco Preamble Xxxxxxx Holdco Securities Recital Outside Date Section 11.1(f) Outstanding Specified Indemnity Claims Section 9.2(a) Owned Domain Names Section 4.17(a) Owned Registered Intellectual Property Section 4.21(a4.17(a) Confidentiality Agreement Pay-off Amount Section 11.10 Constituent Companies 10.2(g) Payment Schedule Section 2.2(a2.4(a) Contributions Recitals Converted Warrant Pensions Act Section 3.4 Corporate Records 4.15(l) Permits Section 4.7(a4.14 Privacy Requirements Section 4.17(l) D&O Indemnified Proposed Resolution Section 2.4(b)(ii) Purchase Price Excess Section 2.4(c)(i) Real Property Lease Section 4.20(b) Reference Date Section 4.14 Representations and Warranties Policy Section 8.15 Restricted Period Section 8.23(a) Restricted Target Section 8.23(a) Securities Act Section 7.6 Seller Released Parties Section 6.8(a8.13(a) Effective Time Seller Releasors Section 2.4(b8.13(b) ERISA Sellers Preamble Sellers’ Representative Preamble Sidley Section 4.13(a12.16 Shortfall Section 2.4(c)(ii) Exchange Agent Social Media Accounts Section 3.2(a4.17(a) Expenses Cap Solvent Section 8.7(b7.5 Specific Policies Section 2.4(d) Export Approvals Specified Indemnity Escrow Account Section 4.26(a2.3(b)(vi) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Specified Indemnity Survival Period Section 10.1(g9.2(a) HCM Expenses Cap SR Agreements Section 8.7(b8.14(a) HCM Expenses Overrun Third Party Claim Section 8.7(b9.3(a) HCM Financial Statements U.S. C-Corp Group Company Section 5.6(d4.19(cc) HCM Indemnified Parties Voting Company Debt Section 6.8(a4.2(c) HCM SEC Filings Voting Management Holdco Debt Section 5.5 HCM Securities 6.2(b) Voting ZMC Blocker Debt Section 5.12(a5.2(b) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS WARN Act Section 5.6(a4.18(l) K&S willful and intentional breach Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo 11.2 ZMC Blocker Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement ZMC Blocker Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Recital ZMC Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7Preamble

Other Defined Terms. Term Location 2022 Terms Section Acquiror Preamble Acquiror Class B Holder Consent 5.2(a) Acquiror Cure Period 10.1(g) Acquiror Debt Transactions 8.5 Acquiror Disclosure Letter Article V Acquiror Expense Reimbursement 10.3(d) Acquiror Fairness Opinion 9.1(i) Acquiror Financial Statements 5.6(c) Acquiror Indemnified Parties 7.8(a) Acquiror Intervening Event 8.2(b)(ii) Acquiror Intervening Event Notice 8.2(b)(ii) Acquiror Intervening Event Notice Period 8.2(b)(ii) Acquiror Option 3.3(a) Acquiror PIPE Investment 8.5 Acquiror PIPE Investor 8.5 Acquiror Restricted Stock 3.3(b) Acquiror SEC Filings 5.5 Acquiror Securities 5.12(a) Acquiror Shareholders’ Meeting 8.2(b) Acquiror Stock Warrant 3.3(a) Acquiror Termination Payment 10.3(b) 18 Terms Section Additional Audited Financial Statements Section 6.3 2023 Additional Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Required Financial Statements 6.3 Additional Transactions 8.5 Additional Unaudited Financial Statements 6.3 Affiliate Agreements Section 4.12(a)(vii4.10(a)(xi) Agreement Preamble Agreement End Date 10.1(e) Ancillary Agreements Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Carlyle Consent 6.7 Closing Section 2.4(a2.3(a) Closing Date Section 2.4(a2.3(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a4.4(a) Company Consolidated Group 4.20(e) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(bDisclosure Letter Article IV Company Expense Reimbursement 10.3(c) Company Financial Statements 4.6(a) Company Indemnified Parties Section 6.8(a7.8(a) Company Real Insurance Policies 4.14 Company Intellectual Property Section 4.20(a1.1 Company Material Contracts 4.10(a) Company Material Customers 4.11(a) Company Material Vendors 4.11(b) Company Preferred Stock 4.4(a) Company Qualified Benefit Plan 4.18(b) Company Registered Intellectual Property 4.13(a) Company Registered IP 4.13(a) Company Series D-4 Preferred Stock 4.4(a) Company Series D-5 Preferred Stock 4.4(a) Company Series D-6 Preferred Stock 4.4(a) Company Series D-7 Preferred Stock 4.4(a) Company Series D-8 Preferred Stock 4.4(a) Terms Section 4.21(aCompany Software 4.13(a) Company Termination Payment 10.3(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(aCorporations 2.1(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(aConstituent Entities 2.1(c) Continental 5.8 Xxxxxx 11.18(a) Xxxxxx Privileged Communications 11.18(a) Xxxxxx Waiving Parties 11.18(a) Xxxxxx XX Group 11.18(a) D&O Indemnified Parties Section 6.8(a7.8(a) DGCL Recitals Dissenting Shares 3.5 Domesticated Acquiror Certificate of Incorporation 7.7 Domesticated Acquiror Common Stock Recitals Domestication Recitals Effective Time Section 2.4(b2.3(b) ERISA Section 4.13(a4.18(b) ESPP 7.1(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(bExchange Agent Termination Date 3.2(a) Export Approvals Section 4.26(aExpense Reimbursements 10.3(d) Extended End Date Section 10.1(hExtension Meeting 8.7(d) Extension Proposal 8.7(a) Extension Proxy Statement 8.7(a) Financial Statements Section 4.7(a)(ii4.6(a) FTA Section 4.15(yFirst Effective Time 2.3(b) Government Contract Section 4.29 HCM First Merger Certificate 2.1(a) First Merger Sub Preamble HCM Cure Period Section 10.1(gFirst Sponsor Designee 7.6(a) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Governmental Approval 4.5 Incentive Equity Plan Section 6.10(a7.1(a) Individual Financial Statements Section 4.7(a)(iiIndependent Director 7.6(a) Intended Tax Treatment Initial Constituent Corporations 2.1(a) Initial Surviving Corporation Recitals Interim Period Section 6.1 Interim Unaudited Company Financial Statements 4.6(a) Interim Unaudited Solaria Financial Statements 4.6(a) JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings 4.10 20 Terms Section 4.10 Letter of Transmittal Section 3.2(b) Liabilities 4.8(a) Listing Application Section 6.7 7.3 Lock-Up Agreement Recitals Merger Certificate 2.1(a) Mergers Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(bNYSE 5.6(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e7.8(e) Owned Land 4.12(b) Xxxx Xxxxxxxx 11.18(b) Xxxx Xxxxxxxx Privileged Communications 11.18(b) Xxxx Xxxxxxxx Waiving Parties Preamble Party Preamble 11.18(b) Xxxx Xxxxxxxx WP Group 11.18(b) Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) 4.16 Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b4.12(c) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller SCI Consent 6.8 Second Effective Time 2.3(b) Second Merger Certificate 2.1(c) Second Merger Sub Preamble Sponsor Parties Recitals Surviving Company Recitals Solaria Financial Statements 4.6(a) Solaria Series D Preferred Stock 4.4(a) Subscription Agreement 8.5 Tangible Assets 4.12(a) Terminating Acquiror Breach 10.1(g) Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(aTermination Payments 10.3(b) Transaction Litigation Section 8.6 7.10 Transaction Proposals Section 8.2(b) Treasury Share 3.1(a) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7U.S. Tax Treatment 2.7(a) Unaudited Company Financial Statements 4.6(a) Unaudited Solaria Financial Statements 4.6(a)

Other Defined Terms. The following terms shall have the meanings defined for such terms in the Sections set forth below: Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Section 6.3 10% ESOP Quota 19.16 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(viiNumber 7.4(b) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Alternative Plan 19.11(b) Arbitration Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b20.6(a) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Business Recitals Company Preamble Confidential Information 19.10(a) Co-Sale Notice 10.1 Dian Guan Preamble Dispute 20.6(a) Domestic Companies Preamble Drag Holders 15.1 Drag-Along Notice 15.1 Drag-Along Sale 15.1 Dragged Holders 15.1 Effective Date Preamble Exempt Registrations 3.4 Exercising Shareholder 9.2(c) First Participation Notice 7.4(a) First Participation Period 7.4(a) HK Company Benefit Plan Section 4.13(aPreamble HKIAC 20.6(b) Company Common Stock Section 4.5(aHKIAC Rules 20.6(b) Company Cure Investor’s Partners 19.15 Jifen Preamble New ESOP 18.1(f) New ESOP Anti-dilution Right 19.16 New Securities 7.3 Observer 17.1 Offered Shares 9.1 Offeror 15.1 Option Period Section 10.1(e9.2(a) Company Expenses Overrun Section 8.7(bOrdinary Director 17.1 Ordinary Shareholder Preamble Oversubscription Participants 7.4(b) Company Indemnified Parties Section 6.8(aParticipation Notice 7.4(b) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Participation Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e7.4(b) Parties Preamble Party Preamble Personal Information Laws and Policies Permitted Transferee 12.1 Permitted Transferees 12.1 11 Shareholders’ Agreement Term Section 4.22(aPreemptive Pro Rata Share 7.2 Preemptive Right 7.1 Principal Preamble Principal Holding Companies Preamble Principal Holding Company Preamble Principals Preamble Prohibited Transfer 13.1 Put Consideration 19.17(a) Processors Section 4.22(aPut Notice 19.17(b) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(iPut Right 19.17(a) Proxy Statement/Qukandian Preamble Re-allotment Period 9.2(c) Restricted Business 19.8 ROFR Pro Rata Share 9.2(b) Second Notice 9.2(c) Second Participation Notice 7.4(b) Second Participation Period 7.4(b) Selling Shareholder 10.1 Series A Director 17.1 Series A Investor Preamble Series A Investors Preamble Series A Share Purchase Agreement Recitals Series A Shareholders Agreement Recitals Series A1 Investor Preamble Series A1 Share Purchase Agreement Recitals Series A1 Shareholders Agreement Recitals Series B1 Director 17.1 Series B1 Investor Preamble Series B1 Share Purchase Agreement Recitals Shelf Period 2.2(a) Shelf Registration Statement Section 8.2(a)(i2.2 Shelf Takedown Request 2.2(b) PubCo Subpart F Income 19.15 Tokens 19.18 Transfer 8.1 Transfer Notice 9.1 Transferor 9.1 Tuile Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iiiVIE Event 19.11(b) Registrar Section 2.4(bViolation 5.1(a) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller WFOE Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7Xike Preamble Zhangduan Preamble

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Number Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii7.4(b) Agreement Preamble Ancillary Approved Sale Section 11.1 CEO Director Section 9.1(a)(iv) Chinook Recitals Chinook [***] Section 9.1(a)(i) Chinook [***] Section 9.5 Company Preamble Confidential Information Section 13.6(a) Co-Sale Notice Section 10.3(a) Covered Employee Section 13.8 Direct U.S. Investor Section 13.5(c) Dispute Section 14.6(a) Drag Holders Section 11.1 Effective Date Preamble Exempt Registrations Section 3.5 Exercising Shareholder Section 10.2(c)(iii) First Participation Notice Section 7.4(a) Xxxxxxx [***] Section 9.1(a)(ii) Xxxxxxx [***] Section 9.5 Group Affiliates Section 13.1(b) HK Subsidiary Preamble ICC Rules Section 14.6(a) Indirect U.S. Investor Section 13.5(c) Investor/Investors Preamble 7 Shareholders Agreement Investor Director/Investor Directors Section 9.1(a)(iii) Joint [***] Section 9.5 License Agreement Recitals New Securities Section 7.3 Observer/Observers Section 9.5 Offered Shares Section 10.2(a) Option Period Section 10.2(c)(i) Ordinary Shareholder/Ordinary Shareholders Preamble Other Restriction Agreements Section 11.10 Authorization Notice 10.1(f) Oversubscription Participants Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance 7.4(b) Participating Investor Section 11.18(b7.4(a) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Party/Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Permitted Transferee and Permitted Transferees Section 10.1(g) HCM Expenses Cap PFIC Shareholder Section 8.7(b13.5(c) HCM Expenses Overrun Pivotal [***] Section 8.7(b9.1(a)(iii) HCM Financial Statements Pivotal [***] Section 5.6(d9.5 Preemptive Pro Rata Share Section 7.2 Preemptive Right Section 7.1 Prohibited Transfer Section 10.5 Purchase Agreement Recitals Restricted Holder Section 10.1(a) HCM Indemnified Parties Restricted Party Section 6.8(a13.8 ROFR Pro Rata Share Section 10.2(c)(ii) HCM SEC Filings Second Notice Section 5.5 HCM Securities 10.2(c)(iii) Second Participation Notice Section 5.12(a7.4(b) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Second Participation Period Section 6.1 JOBS Act 7.4(b) Selling Shareholder Section 5.6(a10.3(a) K&S Shareholder Representative Section 11.18(a11.1(g) K&S Privileged Communications Subsidiary Board Section 11.18(a9.1(b) K&S Waiving Parties Transfer Section 11.18(a10.1(a) K&S WP Group Transfer Notice Section 11.18(a10.2(a) Legal Proceedings Transferee Section 4.10 Letter of Transmittal 10.2(a) Transferor Section 3.2(b10.2(a) Listing Application Violation Section 6.7 Lock-Up Agreement Recitals Merger Recitals Merger Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.75.1(a)

Other Defined Terms. Term Location 2022 Audited Financial Statements The following terms shall have the meanings defined for such terms in the Sections set forth below: Additional Number Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii7.4(ii) ADV Schedule B ADV I ADV II Schedule B Schedule B Agreement Preamble Ancillary Agreements Section 11.10 Authorization Arbitration Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b21.6(i) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Boqii Corporation Preamble Boqii International Preamble Business Recitals Company Preamble Competitor Section 8.2 Confidential Information Section 20.15(i) Co-Sale Notice Section 10.1 CMB Schedule B CW Schedule B Dispute Section 21.6(i) Domestic Company Benefit Plan Preamble Drag-Along Notice Section 4.13(a15.1 Drag-Along Sale Section 15.1 Dragged Holders Section 15.1 Drag Holders Section 15.1 Effective Date Preamble ESOP Section 7.3 (iv) Exempt Registrations Section 3.4 Exercising Shareholder Section 9.2(iii) First Participation Notice Section 7.4(i) GLO Schedule B GS Schedule B HK Companies Preamble HKIAC Section 21.6 (ii) HKIAC Rules Section 21.6 (ii) Holding Company Common Stock Preamble Information Section 4.5(a) Company Cure 21.30 Investor Preamble Investor Option Period Section 10.1(e8.2(i) Company Expenses Overrun Investor ROFR Notice Section 8.7(b8.2(i) Company Indemnified Parties Investor ROFR Shares Section 6.8(a8.2(i) Company Real Property JAFCO Schedule B JAFCO Manager Section 4.20(a21.10(ii) Company Registered Intellectual Property JIAP Section 4.21(a21.10(ii) Confidentiality Agreement Liquidation Preference Exception Section 11.10 Constituent Companies 20.19 XXX Preference Amount Section 2.2(a20.19(ii) Contributions Recitals Converted Warrant MTL Schedule A MTL Preference Amount Section 3.4 Corporate Records 20.19(i) Money Laundering Laws Section 4.7(a20.6(i) D&O Indemnified Parties New Securities Section 6.8(a) Effective Time 7.3 Observer Section 2.4(b) ERISA 17.4 ODI Covenants Section 4.13(a) Exchange Agent 20.3 Offered Shares Section 3.2(a) Expenses Cap 9.1 Offeror Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure 15.1 Option Period Section 10.1(g9.2(i) HCM Expenses Cap Ordinary Directors Section 8.7(b17.1(i) HCM Expenses Overrun Ordinary Investor Preamble Other Restriction Agreements Section 8.7(b8.6 Oversubscription Participants Section 7.4(ii) HCM Financial Statements Partnership Election Section 5.6(d20.12(i) HCM Indemnified Parties Party Preamble Permitted Transferee Section 6.8(a12.1 PRC Companies Preamble Redemption Exception Section 18.1(b)(ii) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Relevant Period Section 6.1 JOBS Act 8.2 Restricted Business Section 5.6(a20.10 Rights Holder Section 7.1 ROFR Pro Rata Share Section 9.2(ii) K&S Principal Preamble Preemptive Pro Rata Share Section 11.18(a7.2 Preemptive Right Section 7.1 Prohibited Transfer Section 13.1 Purchase Agreement Preamble Second Notice Section 9.2(iii) K&S Privileged Communications Second Participation Notice Section 11.18(a7.4(ii) K&S Waiving Parties Second Participation Period Section 11.18(a7.4(ii) K&S WP Group Security Holder Section 11.18(a20.2 Selling Shareholder Section 10.1 Series A Director Section 17.1(i) Legal Proceedings Series A Investor Preamble Series B Director Section 4.10 Letter of Transmittal 17.1(i) Series B Investor Preamble Series C Investor Preamble Series C+ Director Section 3.2(b17.1(i) Listing Application Series C+ Investor Preamble Series C+ Options Section 6.7 Lock-Up 20.18(iii) Series C+1 Option Section 20.18(ii) Series C+1 Preferred Shares Section 20.18(ii) Series C+2 Option Section 20.18(iii) Series C+2 Preferred Shares Section 20.18(iii) Series D Director Section 17.1(i) Series D Investor Preamble Series D-1 Investors Preamble Series D-2 Investors Preamble Series D—3 Investor Preamble Series E Director Section 17.1(i) Series E Investors Preamble Ninth Shareholders Agreement Recitals Merger Recitals Merger Right Subsidiary Board Section 3.1(a17.1(ii) Modification in Recommendation Transfer Notice Section 8.2(b9.1 Transferor Section 9.1 UOB Investment Schedule B U.S. Shareholder Section 20.12(iii) Multiemployer Plan Violation Section 4.13(b5.1(i) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.7WFOE Preamble

Other Defined Terms. Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Section 6.3 Additional Deposit The following terms shall have the meanings defined for such terms in the Sections set forth below: Aggregate Principal Amount Section 7.6 Affiliate Agreements Section 4.12(a)(vii11.17(g) Agreement Preamble Ancillary Agreements Section 11.10 Authorization Alibaba Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Period Section 10.1(e) Company Expenses Overrun Section 8.7(b) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) Effective Time Section 2.4(b) ERISA Section 4.13(a) Exchange Agent Section 3.2(a) Expenses Cap Section 8.7(b) Export Approvals Section 4.26(a) Extended End Date Section 10.1(h) Financial Statements Section 4.7(a)(ii) FTA Section 4.15(y) Government Contract Section 4.29 HCM Preamble HCM Cure Period Section 10.1(g) HCM Expenses Cap Section 8.7(b) HCM Expenses Overrun Section 8.7(b) HCM Financial Statements Section 5.6(d) HCM Indemnified Parties Section 6.8(a) HCM SEC Filings Section 5.5 HCM Securities Section 5.12(a) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S of Intent Section 11.18(a) K&S Privileged Communications Alibaba Specific Competitors Section 11.18(a) K&S Waiving Parties Arbitration Notice Section 11.18(a12.5(a) K&S WP Beneficial Owner Section 11.16(d) Beneficial Ownership Section 11.16(d) Business Recitals Change of Control Event Section 11.17(i) Chengzi Shanghai Schedule A-1 Cheering Venture Schedule A-1 Company Preamble Confidential Information Section 11.13(a) Didi China Technology Schedule A-1 Didi Commercial Service Schedule A-1 Didi Domestic Company Schedule A-1 Didi Domestic Sub Schedule A-1 Didi HK Company Schedule A-1 Didi HK Technology Schedule A-1 Didi Group Preamble Didi Group Company Preamble Didi Principal Holding Company Preamble Didi Principals Preamble Didi Research Schedule A-1 Didi Share Group Section 11.18(a11.17(f) Legal Proceedings Didi Traveling Schedule A-1 Didi WFOE Schedule A-1 Direct US Investor Section 4.10 Letter of Transmittal 11.12(c) Dirun Tianjin Schedule A-1 Disbursement Date Section 3.2(b11.17(g) Listing Application Disposal Section 6.7 Lock-Up 11.17(i) Ditu Schedule A-1 Exempt Registrations Section 3.4 Filing Agent Section 11.17(b) Filing Documents Section 11.17(b) Filing Shareholders Section 11.17(a) First Participation Notice Section 7.4(a) Full Le Schedule A-1 HKIAC Section 12.5(b) HKIAC Rules Section 12.5(b) Indemnification Agreement/Indemnification Agreements Section 9.8 Independent Filing Shareholder Section 11.17(c) Indirect US Investor Section 11.12(c) Jiangxing Chengzi Schedule A-1 K Full Schedule A-1 Kuaidi Recitals Kuaidi Domestic Company Schedule A-2 Kuaidi HK Company Schedule A-2 Kuaidi Group Preamble Kuaidi Group Company Preamble Kuaidi Share Group Section 11.7(f) Kuaidi WFOE Schedule A-2 Majestic Schedule A-1 Management Director Section 9.1(a) Merger Agreement Recitals Merger Recitals Merger New Securities Section 7.3 Non-Voting Director Section 9.9 Oversubscription Participants Section 7.4(b) Party/Parties Preamble PFIC Shareholder Section 11.12(c) Power of Attorney Section 11.17(a) Preemptive Right Section 3.1(a) Modification in Recommendation Section 8.2(b) Multiemployer Plan Section 4.13(b) Nasdaq Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a) Prospectus Section 11.1 Proxy Statement Section 8.2(a)(i) Proxy Statement/Registration Statement Section 8.2(a)(i) PubCo Preamble PubCo Reorganization Recitals Q3 Financial Statements Section 6.3 Real Property Leases Section 4.20(b)(iii) Registrar Section 2.4(b) Registration Rights Agreement Recitals Registration Statement Securities Section 8.2(a)(i) Reorganization Recitals Reorganization Documentation Section 6.6 Seller Preamble Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Section 10.1(e) Terminating HCM Breach Section 10.1(g) Title IV Plan Section 4.13(b) Top Vendors Section 4.28(a) Transaction Litigation Section 8.6 Transaction Proposals Section 8.2(b) Trust Account Section 11.1 Trust Agreement Section 5.8 Trustee Section 5.8 Warrant Assumption Agreement Section 3.4 Warrant Exchange Section 3.4 Written Objection Section 7.77.1

Other Defined Terms. The following terms shall have the meanings defined for such terms in the Sections set forth below: Term Location 2022 Audited Financial Statements Section 6.3 2023 Financial Statements Action Section 6.3 Additional Deposit Amount 8.1 Adverse Disclosure Section 5.1(b) Applicable Shares Section 10.1(a) Automatic Shelf Registration Statement Section 5.1(b) Blue Spectrum Holder Section 5.1(a) Buyer Recitals Call Right Section 10.1(a) Xxxxxxx Xxxxxx Section 5.1(c) Carlyle Nominee Section 2.1(c)(i) Carlyle VI Preamble Cause Section 10.7(a) Code Section 10.7(b) Company Preamble Consultant Section 10.7(c) Corporate Entity Section 7.6 Affiliate Agreements CP VI Coinvestment A Preamble CP VI Coinvestment B Preamble CP VI Holdings Preamble Demand Delay Section 4.12(a)(vii5.3(a)(ii) Agreement Preamble Ancillary Agreements Demand Holder Section 11.10 Authorization Notice Section 7.7 Cash Contribution Recitals Cayman Companies Act Recitals Xxxxxxxx Chance Section 11.18(b5.3(a) Clifford Chance Privileged Communications Section 11.18(b) Clifford Chance Waiving Parties Section 11.18(b) Clifford Chance WP Group Section 11.18(b) Closing Section 2.4(a) Closing Date Section 2.4(a) Code Recitals Company Preamble Company Benefit Plan Section 4.13(a) Company Common Stock Section 4.5(a) Company Cure Demand Period Section 10.1(e5.3(c) Company Expenses Overrun Demand Registration Section 8.7(b5.3(a) Company Indemnified Parties Section 6.8(a) Company Real Property Section 4.20(a) Company Registered Intellectual Property Section 4.21(a) Confidentiality Agreement Section 11.10 Constituent Companies Section 2.2(a) Contributions Recitals Converted Warrant Section 3.4 Corporate Records Section 4.7(a) D&O Indemnified Parties Section 6.8(a) 15 Effective Time Section 2.4(b11.19 Eligible Tag-Along Stockholder Section 4.4(a) ERISA Eligible Take-Down Holder Section 4.13(a5.1(e) Exchange Agent Employee Section 3.2(a10.7(d) Expenses Cap Employee Equity Arrangement Section 8.7(b7.1 Financial Investor Holder Section 5.1(f) Export Approvals GIC Holder Section 4.26(a5.1(g) Extended End Date H&F Holder Section 10.1(h5.1(f) Financial Statements H&F Nominee Section 4.7(a)(ii2.1(c)(i) FTA HFCP VII Preamble HFCP VII Executives Preamble HFCP VII Parallel Preamble HFCP VII Parallel-A Preamble HFCP VIII Preamble HFCP VIII Associates Preamble HFCP VIII Executives Preamble HFCP VIII Parallel Preamble HFCP VIII Parallel-A Preamble Holder Section 4.15(y5.1(i) Government Contract Holders Section 4.29 HCM 5.1(i) Holdings Recitals Indemnification Sources Section 8.2 Indemnified Liabilities Section 8.1 Indemnified Party Section 5.7(c) Indemnifying Party Section 5.7(c) Indemnitee-Related Entities Section 8.2 Indemnitees Section 8.1 Initial Blue Spectrum Entities Preamble HCM Cure Period Initial Carlyle Entities Preamble Initial GIC Entities Preamble Initial H&F Entities Preamble In-Kind Distribution Section 10.1(g4.1(f) HCM Expenses Cap Jaguar I Recitals Joinder Agreement Section 8.7(b4.1(d) HCM Expenses Overrun Jointly Indemnifiable Claims Section 8.7(b8.2 Litigation Section 11.8(a) HCM Financial Statements Manager Group Representative Section 5.6(d11.14 Manager Side Agreements Section 3.1(e) HCM Indemnified Parties Marketed Take-Down Notice Section 6.8(a5.2(d)(iii) HCM SEC Filings Marketed Underwritten Shelf Take-Down Section 5.5 HCM Securities Section 5.12(a5.2(d)(iii) HCM Shareholders’ Meeting Section 8.2(b) HoldCo Preamble Incentive Equity Plan Section 6.10(a) Individual Financial Statements Section 4.7(a)(ii) Intended Tax Treatment Merger Recitals Interim Period Section 6.1 JOBS Act Section 5.6(a) K&S Section 11.18(a) K&S Privileged Communications Section 11.18(a) K&S Waiving Parties Section 11.18(a) K&S WP Group Section 11.18(a) Legal Proceedings Section 4.10 Letter of Transmittal Section 3.2(b) Listing Application Section 6.7 Lock-Up Merger Agreement Recitals Merger Sub Recitals Merger Right Offer Shares Section 3.1(a4.4(a) Modification in Recommendation Parent Stockholder Section 8.2(b1.3(d) Multiemployer Plan Participation Subsidiaries Section 4.13(b7.5 Pre-Closing H&F Entities Preamble Prior Agreement Recitals Pro Rata Take-Down Share Section 5.2(d)(ii)(C)(1) Nasdaq Proposed Transferee Section 4.4 New CayCo Preamble Offer Documents Section 8.2(a)(i) Other Indemnitors Section 6.8(e) Parties Preamble Party Preamble Personal Information Laws and Policies Section 4.22(a) Processors Section 4.22(a4.4(a) Prospectus Section 11.1 Proxy Statement 5.1(j) Record Holder Stockholder Section 8.2(a)(i1.3(d) Proxy Statement/register Section 5.1(k) registered Section 5.1(k) Registrable Securities Section 5.1(l) registration Section 5.1(k) Registration Expenses Section 5.1(m) Registration Statement Section 8.2(a)(i5.1(k) PubCo Preamble PubCo Reorganization Merger Recitals Q3 Financial Statements Repurchase Note Section 6.3 Real Property Leases 10.4 Repurchase Period Section 4.20(b)(iii10.1(a) Registrar Repurchase Price Section 2.4(b10.3 Restricted Shelf Take-Down Section 5.2(d)(ii)(A) Registration Rights Agreement Recitals Restricted Shelf Take-Down Notice Section 5.2(d)(ii)(A) Restricted Take-Down Participation Notice Section 5.2(d)(ii)(B) Restricted Take-Down Selling Holders Section 5.2(d)(ii)(A) Sale Notice Section 4.4(a) Service Provider Section 10.7(e) Shelf Holder Section 5.2(a) Shelf Percentage Section 5.1(n) Shelf Period Section 5.2(b) Shelf Registration Statement Securities Section 8.2(a)(i5.1(o) Reorganization Recitals Reorganization Documentation Shelf Suspension Section 6.6 Seller Preamble 5.2(c) Shelf Take-Down Section 5.1(p) Shelf Take-Down Percentage Section 5.2(d)(ii)(A) Sponsor Parties Recitals Surviving Company Recitals Terminating Company Breach Holder Section 10.1(e5.1(q) Terminating HCM Breach Spousal Consent Section 10.1(g3.2(g) Title IV Plan Stockholder Sellers Section 4.13(b4.4(a) Top Vendors Tag-Along Right Section 4.28(a4.4(c)(i) Transaction Litigation Tag-Along Sale Period Section 8.6 Transaction Proposals 4.4(c)(i) Tag-Along Sellers Section 8.2(b4.4(b) Trust Account Tag-Along Shares Section 11.1 Trust Agreement 4.4(b) Tag-Along Stockholder Section 5.8 Trustee 4.4(b) Take-Down Tagging Holders Section 5.8 Warrant Assumption Agreement 5.2(d)(ii)(A) Termination of Service Section 3.4 Warrant Exchange 10.7(f) Third Party Holder Section 3.4 Written Objection 5.1(r) Third Party Shelf Holder Section 7.75.2(a) Well-Known Seasoned Issuer Section 5.1(s)